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The goals of my research project were to clone the E(var)3-5 gene and 
characterize the lethality of E(var)3-5 mutations. The E(var)3-5 gene was 
identified by dominant mutations that enhanced PEV of wm4, thus implicating the 
gene product in promoting a euchromatic chromatin structure (Dorn et al. 1993). 
These mutations were found to be recessive lethal as well and the lethal 
phenotype was used to map the E(var)3-5 gene (Dorn et al. 1993; this work). I 
characterized the lethality of E(var)3-5 mutations and found that lethality in 
E(var)3-5 hemizygotes is manifested at the pupal stage.  I mapped the lethality to 
a region defined by Df(3R)Exel7310. I generated five FLP-FRT mediated 
deletions within the region defined by Df(3R)Exel7310 however, my 
complementation analysis revealed that E(var)3-5 mutants were not allelic to any 
of the genes in that region. However I identified a mutation in one of the genes, 
CG17360 in all E(var)3-5 mutants examined. The CG17360 mutants exhibit an 
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Chapter 1: Introduction 
 
 Emil Heitz in 1928 first made the cytological distinction between the two 
nuclear compartments, euchromatin and heterochromatin (in Heitz 1928; 
reviewed by Weiler and Wakimoto 1995; Grewal and Elgin 2002). He carefully 
analyzed the pattern of chromosomes in moss cells during the cell cycle and 
observed that some regions of the chromosomes remained condensed during 
the interphase unlike other chromosomal regions. These compact chromosomal 
regions that failed to decondense during the interphase and telophase of the 
mitotic cycle were identified as heterochromatin. Heitz defined euchromatin as 
that part of the genome that condensed during the mitotic phase and 
decondensed during the interphase. Brown (1966) further characterized 
heterochromatin as facultative and constitutive heterochromatin. Facultative 
heterochromatin refers to euchromatic sequences that are condensed for many 
cell generations but can be decondensed. The known examples of facultative 
heterochromatin are the inactive X chromosome in female mammals and the 
repressed paternal set of chromosome in male coccoid bugs (Brown 1966; 
reviewed by Dimitri et al. 2005; Corradini et al. 2007) 
 
Biochemical differences between euchromatin and heterochromatin  
 The two nuclear domains, euchromatin and heterochromatin, can be 
differentiated from each other due to differences in histone modifications. The 
nucleosomes that constitute the basic unit of chromatin consist of 146 bp of DNA 
wrapped around a histone octamer. The histone octamer consists of two subunits 
each of H2A, H2B, H3 and H4 (reviewed by Kornberg and Lorch 1999). The 
histones are subjected to a variety of post-translational modification such as 
acetylation, methylation and phosphorylation (Garcia-Ramirez et al. 1995; Strahl 
et al. 1999; Nowak and Corces 2000). It has been suggested that the pattern of 
histone modification on euchromatin and heterochromatin can govern the 
packaging of chromatin as open and closed states (Strahl and Allis 2000; 
reviewed by Jenuwein and Allis 2001).  
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Acetylation of lysine residues on histone H4 is most studied. In general, 
hyperacetylation of histones is linked to an increase in transcription whereas 
hypoacetylation has been linked to repressive chromatin (Hebbes et al. 1988; 
reviewed by Grunstein 1997; Turner 2000; Turner and O'Neill 1995; Litt et al. 
2001). Munks et al. (1991) have shown that H4 is acetylated on lysine at 
positions 5, 8, 12 and 16 in drosophila cell lines S2 and Kc using antibodies that 
detected all forms of acetylated lysine. In the Drosophila melanogaster polytene 
chromosomes, euchromatic bands and interbands are associated with H4 
acetylated at positions 5 and 8 whereas the heterochromatic regions are marked 
with acetylated H4K12. The X chromosome in D. melanogaster males was 
shown to be enriched in H4K16 (Turner et al. 1992; Bone et al. 1994).  
 Methylation of lysine residues on histones H3 and H4 has been intensively 
researched. On histone H3 lysine can be methylated at positions 4, 9, 27 and 36. 
On histone H4 lysine can be methylated at position 20. The lysine residues on 
H3 and H4 can be mono, di and tri-methylated (reviewed by Cheung and Lau 
2005; Lachner et al. 2003). In D. melanogaster, methylated H3K4 is a major 
euchromatic mark and has been shown to be associated with interband regions 
(Ebert et al. 2006). Schubelar et al. (2004) also provided experimental evidence 
indicating that promoters of active genes are enriched in methylated H3K4 
(Schubeler et al. 2004). However in a recent investigation by Yasuhara and 
Wakimoto (2008) on histone modification pattern, it was reported that 5’ region of 
Moca-cyp, CG1646 and CG5514  are not enriched in H3K4me2, but rather are 
enriched in H3K9 modification (Yasuhara and Wakimoto. 2008). Several 
enzymes such as ASH1, TRX and TRR that possess H3K4 methyltransferase 
activity have been identified (Beisel et al. 2002; Sedkov et al. 2003; Byrd and 
Shearn 2003) 
 In Drosophila melanogaster, mono and dimethylation of lysine 9 and 
methylation of K27 on H3, as well as trimethylation of H4 at K20, are considered 
as major heterochromatic marks (Ebert et al. 2006). However methylated H3K27 
and trimethylated H4K20 are also detected in some euchromatin regions. 
Su(var)3-9 has been identified as the predominant H3K9 methytransferase in D. 
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melanogaster (Schotta et al. 2002). Similarly Suv4-20 has been identified as an 
H4K20 methyltransferase (Schotta et al. 2004). The other H3K9 
methytransferase identified in D. melanogaster are dSETDB1 (Tzeng et al. 2007) 
and dG9a (Mis et al. 2006). The dSETDB1 enzyme has been shown to methylate 
H3K9 on euchromatin and chromosome 4 (Seum et al. 2007). dG9a has been 
identified as a multi-catalytic methyltransferase since it methylates H3 on lysine 9 
and 27 and H4 (Stabell et al. 2006). Recently it has been demonstrated that the 
transcribed regions of heterochromatic genes are associated with dimethylated 
H3K9 (Yasuhara and Wakimoto 2008).  
 Phosphorylation on H3 at serine 10 has been associated with transcription  
elongation in fruit flies (Ivaldi et al. 2007). The JIL-1 kinase has been shown to be 
responsible for phosphorylating H3 at S10 (Wang et al. 2001). On the 
euchromatin, JIL-1 kinase has been shown to localize on multiple sites on 
interband region (Yin et al. 1999). Loss of JIL-1 kinase has been shown to cause 
ectopic distribution of heterochromatic marker H3K9me2 and HP1, especially on 
the X-chromosome. JIL-1 kinase has been implicated in maintaining euchromatic 
regions. The JIL-1 kinase  phosphorylates H3 at S10, preventing methylation of 
neighboring H3K9 residue by the Su(var)3-9 methyltransferase. As a result HP1 
cannot bind to H3K9 consequently preventing heterochromatin formation (Zhang 
et al. 2006). 
 
Sequence composition differs between euchromatin and heterochromatin 
 The Drosophila melanogaster genome measures approximately 180 Mb in 
size. The euchromatic sequences comprise about two-thirds of the genome 
whereas one-third of the genome is heterochromatic (Adams et al. 2000; 
reviewed by Celniker and Rubin 2003). The D. melanogaster genome annotation 
predicts about 13,379 protein-coding genes in 116.8 Mb of euchromatic 
sequence. The number of protein coding exons is estimated to be around 54,934 
with an average of 4.6 exons per gene. The euchromatic genome annotation has 
identified complex gene models that are categorized as nested gene, overlapping 
genes, alternatively transcribed genes and dicistronic gene. About 1,038 
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euchromatic genes are categorized as nested genes, which are defined as being 
within the introns of other genes. 15% (2,054) of euchromatic genes are 
described as overlapping genes. About 2,279 are categorized as alternatively 
transcribed genes. Dicistronic genes were defined as genes that produce 
mRNAs containing two separate and non-overlapping coding regions. About 31 
dicistronic genes were identified (Misra et al. 2002; reviewed by Celniker and 
Rubin 2003). An analysis of 24 Mb of heterochromatin was presented in release 
5.1 of the D. melanogaster heterochromatin (Smith et al. 2007). This annotation 
predicted 613 protein-coding genes. 186 single-exon genes and 427 multiple-
exon genes together comprise the 613 predicted genes. Nested, overlapping or 
dicistronic genes have not been identified so far in the friutfly heterochromatin. 
Heterochromatic gene introns are usually five times longer than euchromatic 
gene introns. The increased length of the introns is attributed to the sequence 
composition that consists of fragmented transposable elements. Euchromatin 
has a higher gene density (12.6 gene per 100 kb) than heterochromatin (1.8 to 
4.4 gene per 100 kb). Pseudogenes map to both euchromatin and 
heterochromatin but the density is three times greater in heterochromatin than in 
euchromatin (Smith et al. 2007). 
 Transposable elements (TEs) are an integral part of the D. melanogaster 
genome and are present in both euchromatin and heterochromatin (Adams et al. 
2000). TEs are categorized under two classes based on their mechanism for 
transposition. Class I elements, also known as retrotransposons, require an RNA 
intermediate for transposition. Retrotransposons are further categorized into LTR 
(long terminal repeat) transposons and LINE/SINE (long and short interspersed 
element). Class II elements, also known as transposons, insert themselves into 
the genome through a DNA intermediate. The DNA transposons possess 
terminal inverted repeats and encode their own transposase. A systematic 
analysis of transposable elements in euchromatin was performed by Kaminker et 
al. (2002). About 96 families of transposable elements have been identified so far 
in fruitfly euchromatin. The LTR transposons comprise the majority among TEs in 
euchromatin. About 30-50 different TE families are scattered in the D. 
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melanogaster heterochromatin. Of the 24 Mb of heterochromatin that has been 
curated, about 16 Mb primarily consists of LTR transposons and LINEs (Smith et 
al. 2007). The transposable elements however are incomplete sequences. The 
majority of heterochromatic and euchromatic transposons are found interspersed 
within other elements (Kaminker et al. 2002; Smith et al. 2007). 
 Pimpinelli et al. (1995) analyzed the distribution pattern of 11 different TEs 
using fluorescent in situ hybridization in the heterochromatin of mitotic 
chromosomes. Their study indicated that transposable elements have a tendency 
to cluster in a heterochromatic region. Clustering of transposable elements is not 
affected by the heterochromatic DNA sequence. Analysis of wild-type strains 
from geographically distant populations showed that TE clusters were conserved 
among the populations. The authors thus suggested that transposable elements 
are inherent constituents of heterochromatin (Pimpinelli et al. 1995) 
 About two-third of the heterochromatic DNA of the D. melanogaster 
genome consists of satellite DNA, which is underrepresented in the curated 
regions due to its recalcitrance to cloning (reviewed by Celniker and Rubin 2003). 
The repetitive DNA elements known as satellite DNAs were first identified using 
the technique of cesium chloride density gradient centrifugation. Satellite DNAs 
showed a different buoyant density than the bulk of the DNA in the cesium-
chloride centrifugation, hence the name (Yunis and Yasmineh 1971). Four 
predominant satellite DNAs occur in D. melanogaster heterochromatin. Three of 
these satellite DNAs, namely the 1.672g/cm2, 1.686 g/cm2 and 1.705 g/cm2 
satellites, are known as simple satellites and consist of tandem repeats of 5-10 
bp in length. The fourth satellite DNA with a buoyant-density of 1.688 g/cm2 is a 
complex satellite consisting of tandem repeats of 359 bp (reviewed by Gatti and 
Pimpinelli 1992). The composition of satellite DNAs has been extensively 
analyzed by cloning the 1.672, 1.686 and 1.705 satellite DNAs (Lohe and Brutlag 
1986). Within these clones, the authors identified 11 new repeats consisting of 
repeat units of 5, 7 and 10 bp, which were different from the already documented 
predominant repeats. A mitotic chromosome map depicting the distribution of 
major and minor satellite DNAs on heterochromatin was created by Lohe et al. 
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(1993). The Y and 2nd chromosomes have the highest density of satellite DNAs. 
The AATAT repeats that are the predominant repeats of the1.672 satellite are 
found at 4 sites on the Y chromosome. The 5 bp AAGAG and 7 bp AAGAGAG 
repeats of the 1.705 satellite are found primarily on the 2nd and Y chromosomes 
with a little distribution on the X and 3rd. The predominant AAGAC repeats of the 
1.686 satellite are found at four different sites on the Y chromosome and a single 
site on the 2nd chromosome. The X chromosome heterochromatin is primarily 
composed of 1.688 satellite. Nine simple satellite sequences make up 80% of the 
Y chromosome and 5 simple satellites make up 70% of the 2nd chromosome 
(Lohe et al. 1993).  
 
Position effect variegation (PEV) 
The phenomenon of position effect variegation (PEV) was first discovered 
by Muller in 1930 but was genetically characterized by Schultz in 1936. Muller 
(1930) irradiated flies with X-rays in an attempt to isolate mutants with 
chromosome abnormalities. In one such experiment he discovered flies that 
variegated for eye color. He termed the phenomenon as “eversporting 
displacement”, and speculated it involved a chromosomal abnormality such as an 
inversion, duplication, translocation or deletion (Muller 1930). Jack Schultz 
analyzed the salivary glands of these mutants from Muller’s experiment (Schultz 
1936). In each case he found that variegation was due to a chromosomal 
rearrangement, and speculated that inert chromosomal material 
(heterochromatin) plays a role in variegation. Schultz (1936) suggested that the 
extent of variegation was proportional to the amount of inert chromosomal 
material at the rearrangement breakpoint. We currently appreciate that position 
effect variegation occurs due to displacement of genes into a different 
chromosomal environment and is a general phenomenon (reviewed by Weiler 
and Wakimoto 1995; Grewal and Elgin 2002). A normally expressed euchromatic 
gene undergoes inactivation when placed artificially by chromosomal 
rearrangement next to heterochromatin. The classic example of PEV is the 
inactivation of the white (w) gene in the chromosomal rearrangement In(1)wm4. 
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An inversion displaces the w gene near to a block of centric heterochromatin and 
as a result the w gene is inactivated. However, this inactivation is a variable 
event. In some cells the w gene is repressed whereas in other cells it undergoes 
regular transcription. A white patch within the eye is a result of inactivation of the 
w gene. A red patch within the eye is observed if the w gene is transcribed. This 
event of PEV in Drosophila melanogaster gives rise to flies that have mottled or 
variegated eyes.  
 PEV involving heterochromatic genes has also been demonstrated. 
Schultz first discovered rearrangements involving the heterochromatic light (lt) 
gene (Schultz and Dobzhansky 1934). Anita Hessler (1958) carried out a detailed 
investigation involving the position effect of the lt gene. Hessler isolated 35 
rearrangements that variegated for the expression of the lt gene. The 
rearrangements displaced the heterochromatic lt gene near a block of 
euchromatin. Salivary gland analysis of these rearrangements displayed some 
peculiar characteristics. In all the rearrangements one breakpoint was located 
near the lt gene. The second breakpoint however was located in the distal 
euchromatin of either the X, 2nd or the 3rd chromosomes. Rearrangements with 
breakpoints in the Y or the 4th chromosome were not recovered. Chromosome 
rearrangements with the 2nd breakpoint located in the proximal euchromatin or 
centromeric heterochromatin were not isolated. Hessler thus suggested that 
heterochromatic gene variegation is different from euchromatic gene variegation 
(Hessler 1958). Subsequent studies by Wakimoto and Hearn (1990) on lt gene 
variegation confirmed Hessler’s observation. The heterochromatic gene, rolled 
(rl) also displays variegation as a result of its displacement from a 
heterochromatic environment (Eberl et al. 1993). These observations argued that 
heterochromatic genes required a heterochromatic environment for proper 
expression. Studies that were conducted on lt variegating rearrangements and rl 
variegating rearrangements also showed that the expression of neighboring 2L 
and 2R heterochromatic genes, respectively, was affected (Wakimoto and Hearn 




 Factors affecting PEV 
 A variety of factors such as temperature, dosage of the Y chromosome 
and genetic modifiers influence or modify position effect variegation (reviewed by 
Girton and Johansen 2008). The Y dosage effect is most easily observed in male 
flies.  In XY males bearing a w-variegated inversion, a variegated eye phenotype 
is seen. In XO males, however, the absence of the Y chromosome leads to 
enhancement of PEV. In XYY males, one extra copy of the Y chromosome leads 
to a suppression of PEV (Gowen and Gay 1934). 
 Position effect variegation is also altered by temperature. Hartmann-
Goldstein (1967) extensively studied the effect of temperature on position effect 
variegation. In general, a decrease in temperature enhances the silencing of a 
gene subjected to PEV. For example, variegation of the w and Notch genes due 
to their translocation near the 4th chromosome centromere was analyzed at 25°C, 
19°C and 14°C. Variegation of the w gene was detected as variability in 
pigmentation of Malphigian tubule cells whereas variegation of the Notch gene 
was observed as a wing abnormality. The results indicated that the variegation 
was most severe at 14°C. 
The histone gene complex also modifies PEV. The histone gene complex 
maps to the 2nd chromosomal arm at cytological position 39D2-3 to E1-2, and 
codes for all five histones. To test the effect of histone dosage on PEV, Moore et 
al. (1979) generated five deficiencies encompassing the histone gene complex. 
Df(2L)65 and Df(2L)161 deleted the entire histone gene complex. Df(2L)84 had 
one-breakpoint in the histone gene such that only a part of complex was deleted, 
and Df(2L)1 and Df(2L)12 deleted regions adjacent to histone gene complex. The 
effects of these deficiencies were tested on two variegating rearrangements 
In(1)wm4 and BsvY.  It was observed that deficiencies Df(2L)84, Df(2L)65 and 
Df(2L)161 suppressed the variegation of white gene in In(1)wm4 and Bsv 






PEV and chromatin structure   
Cytological studies have indicated that euchromatic chromosomal 
sequences affected by PEV are visualized as densely packaged regions in 
polytene chromosomes and that the extent of the dense packaging was observed 
to be sensitive to lower temperature, analogous to the sensitivity of gene 
expression to lower temperature (for example Hartmann-Goldstein 1967). 
Zhimulev et al. (1986) studied the chromosomal rearrangement T(1:2)dorvar7, for 
which the chromosomal region 1A-2B7-8 that includes the ecdysone (ecs) locus 
is translocated to the centromeric heterochromatin of the 2nd chromosome. In the 
salivary glands of T(1:2)dorvar7 larvae, the chromosome morphology at the 2B 
region appeared dense, indicating the spread of heterochromatin. In situ 
hybridization experiments showed that heterochromatinization of the 2B region 
made it less accessible to DNA probes derived from the 2B region. The 
heterochromatinized 2B region was also shown to be late-replicating. These 
results led to the proposal that PEV was associated with altered chromatin 
structure (Zhimulev et al. 1986). The w locus has also been studied to observe 
effects of PEV on chromosome morphology. Hayashi et al. (1990) conducted 
experiments to observe changes in chromatin structure associated with In(1)wm4. 
The authors studied the chromosome morphology of the 3C-E region in polytene 
chromosome squashes. They observed that in the In(1)wm4 strain, the 3C-E 
region appeared euchromatic in only 19% of nuclei when compared to a wild-
type strain. An in situ hybridization experiment using the w gene probe to test the 
accessibility of the w locus revealed that In(1)wm4 showed decreased accessibility 
as compared to an unrearranged chromosome. These experiments supported 
the hypothesis that PEV was associated with an altered chromosome structure 
(Hayashi et al. 1990). 
 Molecular methods to assess changes in accessibility of chromatin 
associated with variegation have yielded mixed results. A DNAse I sensitivity test 
of the w gene in the In(1)wm4 strain to analyze changes at the chromatin level in 
the presence and absence of mutations that modify PEV was performed. 
Surprisingly the pattern of DNAse I digestion of the w gene in the In(1)wm4 strain 
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was not significantly different than the In(1)wm4 strain with modifiers (Hayashi et 
al. 1990). Chromosome structure changes associated with position effect 
variegation were also investigated by Wallrath and Elgin (1995). A special P 
element containing the w gene and the hsp26 gene was mobilized throughout the 
genome and lines that were variegating for the expression of the w gene were 
isolated. The insertions in these lines were localized to pericentric 
heterochromatin and telomeric chromatin. A restriction enzyme assay was 
performed on these lines to measure the accessibility of the hsp26 promoter. 
Reduced accessibility to restriction enzymes was observed for the transgenes 
inserted into pericentric heterochromatin. The reduced accessibility of restriction 
enzymes was attributed to altered chromosome structure. In addition, 
micrococcal nuclease digestion of variegating lines revealed a more ordered 
structural array of nucleosomes over the hsp26 promoter than for the non-
variegating lines. These studies provided further evidence that position effect 
variegation causes alterations in the chromosome structure (Wallrath and Elgin 
1995) 
 Biochemical factors that affect histones also affect position effect 
variegation. The effect of non-acetylated and hyperacetylated histones on PEV 
was studied by Mottus et al. (1980).  In(1)wm4 larvae were treated with varying 
concentrations of butyrate and n-propionate, which inhibit histone deacetylase 
activity and consequently increases the level of hyperacetylated histones. It has 
been demonstrated that active chromatin is associated with hyperacetylated 
histones (Davie and Candido 1978). Mottus et al. (1980) observed that 
hyperacetylated histones limited the spread of heterochromatin, consequently 
preventing the inactivation of w gene leading to suppression of PEV (Mottus et al. 
1980).  
 
Models of position effect variegation  
 Different models have been proposed to explain the mechanism 
underlying position effect variegation. Tartof et al. (1984) proposed the boundary 
model to explain the linear propogation of heterochromatin into euchromatic 
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sequences ultimately leading to a variegated phenotype. In their experiments the 
authors addressed basic questions pertaining to PEV such as the specificity of 
heterochromatic sequences that induce PEV, the nature of sequence at the 
heterochromatin-euchromatin junction, and the involvement of sequences other 
than heterochromatic sequences to cause variegation. To clarify these questions 
three strains variegating for the expression of the white gene, wm4, wmMc and 
wm51b, were studied. The strains appeared to represent simple inversions where 
the white locus was placed next to heterochromatin. Molecular analysis of 
sequences at the heterochromatin-euchromatin junction of the three variegating 
rearrangements revealed transposon-like sequences. This suggested that 
transposon-like sequences might be responsible for inducing PEV. The 
variegating strains were irradiated by X-rays to obtain revertants. Analysis of 
revertants would clarify if the transposon-like sequences at the heterochromatin-
euchromatin junction would lead to a variegated phenotype. Restriction enzyme 
digestion and in situ hybridization experiments revealed that the revertant 
chromosomes still contained some heterochromatin-derived sequences adjoining 
the w locus. These results indicated that the transposon-like sequences were not 
responsible by themselves to induce a variegated phenotype.  Based on their 
results the authors proposed the boundary model to explain heterochromatin 
induced gene silencing (Figure 1.1). According to this model a heterochromatic 
domain is formed between two initiator sites (i). A heterochromatin domain can 
also be formed between the initiator site (i) and the terminator site (t). 
Heterochromatinization of the DNA sequence starts at this initiator site and 
terminates at the t site. A variegated phenotype appears due to a breakpoint 
between the two i sites or between the i the t sites. Such initiation and 
termination sites are dispersed within a heterochromatic block (Tartof et al. 
1984). However, Experimental evidence proving the existence of initiation sites 





Figure 1.1 Boundary model for heterochromatin formation  
 
The X chromosome is shown with the box representing heterochromatin, the line 
representing euchromatin and the circle indicating the centromere. The black 
block represents two initiation sites (i) for heterochromatin formation. A  In an 
unrearranged chromosome, the heterochromatic domain is formed between the i 
sites.  B In the variegating inversion chromosome, the w+ gene undergoes 
silencing when displaced next to heterochromatin due to its spread.  Figure 
adapted from Tartof et al. (1989). 
 
Another model by Karpen and Spradling (1990) proposed the possibility 
that DNA loss might be responsible for PEV. This theory was based on the 
molecular analysis of a mini-chromosome, Dp(1;f)1187. The mini-chromosome 
was derived from the In(1)sc8 chromosome through deletions of DNA sequence 
both proximal and distal to the scute (sc) locus. As a result, only 9 genes 
including the yellow (y) gene remained adjacent to the heterochromatic 
breakpoint. The y gene displayed PEV that was suppressed on addition of a Y 
chromosome. Southern blot analysis was performed on mini-chromosome DNA 
isolated from salivary glands to assay for any associated changes near the 
heterochromatin-euchromatin junction. The result indicated that heterochromatin 
near the breakpoint was underrepresented. The results also revealed that 
euchromatic sequences located 1.9 kb away from the heterochromatin-
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euchromatin junction were underrepresented. The authors determined that 
euchromatic sequences were highly underrepresented in salivary-gland nuclei 
(39 fold underrepresented on average). A trend was observed in which 
sequences located as far as 54 and 103 kb away were underrepresented only 8 
to 2.4 fold. The addition of a Y chromosome reduced the severity of under-
representation. The authors proposed that under-representation of euchromatic 
sequences near the heterochromatic breakpoint was due to elimination of these 
sequences due to the excision of transposons in heterochromatin, thus giving 
rise to the variegated phenotype (Karpen and Spradling 1990).     
 Wakimoto and Hearn (1990) proposed a nuclear compartmentalization 
model to explain the PEV of heterochromatic genes. It was suggested that a 
nuclear compartment would be formed due to association between 
heterochromatic regions. This nuclear compartment would have the desired 
concentration of proteins for the proper expression of heterochromatic genes. A 
change in the concentration of these heterochromatic proteins would lead to a 
variegated phenotype (Wakimoto and Hearn 1990). 
The compartment model was extended to explain PEV of euchromatic 
genes as well. The somatic pairing model proposed by Dorer and Henikoff (1994) 
effectively explains a mechanism of heterochromatin formation and PEV-induced 
gene silencing. This model was derived from PEV studies of a P[lacW] transgene 
harboring the mini-white gene. In presence of a P transposase, the P[lacW] 
transgene was transposed to obtain fly lines that showed a variegated eye 
phenotype. These investigators determined that the fly lines that variegated for 
mini-white expression differed in the copy number and orientation of the P[lacW] 
transgene. In general flies containing three to four tandem repeats showed a 
higher degree of variegation than flies containing one to two repeats. The authors 
suggested that silencing of the mini-white gene occurs as a result of pairing 
between the transgene repeats. The authors hypothesized that the pairing of 
transgene repeats leads to the formation of a hairpin-like structure that 
sequesters the mini-white gene from regulatory elements required for its 
transcription, resulting in silencing. When the transgenes remain unpaired the 
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mini-white gene is transcribed.  Variegation occurs when pairing of transgene 
repeats occurs in some cells but not others. The authors interpreted that 
heterochromatin formation occurs as a result of pairing between transgene 
repeats that are in close vicinity of each other. They proposed that the pairing of 
repeats attracted heterochromatin-specific proteins, giving rise to a 
heterochromatic chromocenter. Similarly, heterochromatin formation might be 
due to association of natural transposon sequences. Heterochromatin formation 
by these natural transposons would be independent of specific transposon 
sequences but would be dependent upon the length and number of transposons 
(Dorer and Henikoff 1994). 
 The euchromatic brown (bw+) gene is a well-studied example for PEV of 
euchromatic gene. The somatic pairing model was used by Sabl and Henikoff 
(1996) to explain heterochromatin formation and PEV-induced gene silencing 
using P[bw+] transposons containing the brown gene. X-ray mutagenesis of flies 
containing the P[bw+] transposon yielded fly lines that exhibited variegated eye 
phenotype.  Molecular analyses of these variegating fly lines indicated that they 
differed in copy number and orientation of the P[bw+] transposons. Fly lines that 
contained a high copy number of transposon repeat exhibited the lowest 
expression of the bw+ gene. On the other hand fly lines that contained one or two 
of the transposons repeat showed increased expression of the bw+ gene. 
Interestingly, fly lines that contained tandem repeats of the P[bw+] transposons in 
the left orientation showed minimum expression of the bw gene than fly lines 
containing tandem repeats of P[bw+] transposons in right orientation. The  
authors proposed that tandem repeats pair with each other and form complex 
structures that associate with heterochromatin, in turn resulting in inactivation of 
the bw+  gene (Sabl and Henikoff 1996) 
 Csink and Henikoff (1996) investigated PEV involving a  brownDomninant 
(bwD) allele. The bwD has a block of heterochromatin inserted at the bw locus 
that trans-inactivates the other willd-type bw+ copy resulting in a variegated eye 
phenotype. Csink and Henikoff (1996) demonstrated that the extent of 
inactivation of the bw+ gene is influenced by its proximity to heterochromatin. 
 
15 
Chromosomal rearrangements that increased the distance  between bwD and 
centric heterochromatin were obtained. Fluorescent in-situ hybridization studies 
of interphase nuclei containing the rearranged chromosome demonstrated that 
increasing the distance between bwD and centric heterochromatin lead to 
decreased inactivation of the bw+ copy and vice versa. Similarly mutation in PEV 
suppressing genes (discussed below) lead to decreased inactivation of the bw+ 
allele. Csink and Henikoff  thus suggested that the extent of PEV of the bw+ gene 
is dependent on its proximity to heterochromatin and heterochromatic proteins 
are also involved in this process. (Csink and Henikoff 1996) 
 
Modifiers of position effect variegation 
Moore et al. (1979) discovered that deficiency of the histone gene 
complex causes suppression of PEV. This discovery lead to the idea that the 
identification of other proteins involved in chromatin architecture might provide 
insight into the mechanism of PEV. This discovery provoked researchers to 
investigate proteins involved in PEV to better understand the process of 
heterochromatinization or chromosome condensation and chromosome 
assembly (Reuter et al. 1982; Sinclair et al. 1983).  
Dominant modifier mutations were isolated in several different genetic 
screens based on their ability to modify the wm4 rearrangement (Reuter and Wolff 
1981; Reuter et al. 1982; Sinclair et al. 1983; Reuter et al. 1987; Sinclair et al. 
1989).  Genes that when mutated lead to the suppression of PEV were named 
Su(var) genes. Mutation of suppressor genes limits the spread of 
heterochromatin. Suppressor genes are thus implicated in encoding proteins 
essential for heterochromatin formation (Reuter and Wolff 1981; Sinclair et al. 
1983). Genes that when mutated lead to the enhancement of PEV were named 
E(var) genes. Enhancer genes are thus implicated in encoding proteins essential 
for euchromatin formation.  Enhancer genes can function in different ways to 
promote euchromatin formation. Enhancer gene can encode proteins that directly 
inhibit the spread of heterochromatin or indirectly they can inhibit the activity of a 
repressor for a suppressor gene (Sinclair et al. 1989). About 150 PEV modifying 
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genes are estimated to be present in the genome of D. melanogaster (reviewed 
by Schotta et al. 2003). 
 Modifiers genes that exert their effect on gene silencing when present only 
in a single dose are known as haplo-dependent modifiers. For example, a haplo-
dependent suppressor gene causes suppression of PEV when present in a 
single dose. Likewise, haplo-enhancers cause enhancement of PEV when 
present in a single dose. A few modifier genes exert opposite effects on gene 
silencing when duplicated and are known as triplo-dependent modifiers. For 
example a modifier gene identified as a haplo-suppressor with a triplo-enhancer 
effect will cause suppression of PEV when present in a single dose but will 
enhance PEV when present in three doses (reviewed by Schotta et al. 2003).  
  
Su(var) genes 
 Molecular characterization of some suppressor genes has shown that 
these proteins are involved in heterochromatin formation. Heterochromatin 
protein 1 (HP1), was identified as the first non-histone chromosomal protein 
associated with centric heterochromatin (James and Elgin 1986). The Su(var)2-5 
gene is a haplo-suppressor with a triplo-enhancer effect (Eissenberg et al. 1992). 
The HP1 protein is characterized by the presence of an amino-terminal chromo 
domain and a carboxy terminal chromo-shadow domain (Aasland and Stewart, 
1995; Paro and Hogness, 1991). The chromo domain targets HP1 to 
heterochromatic locations. Immunofluorescent studies using antibodies for the 
HP1 protein have shown that HP1 is associated with the 4th chromosome and at 
telomeres on 2R, 3R and X chromosomes (James et al. 1989).  Later studies 
have revealed that HP1 also associates with some euchromatic sites (Fanti et al. 
2003) and HP1 has been implicated in upregulating the Hsp70 gene (Piacentini 
et al. 2003). HP1 has been shown to bind methylated H3K9  through the chromo 
domain, an important step in heterochromatin formation (Bannister et al. 2001). 
 Su(var)3-9 has been identified as a haplo-suppressor and triplo-
dependent enhancer of PEV (Schotta et al. 2002). As noted earlier, Su(var)3-9 
encodes a histone methyltransferase that methylates histone H3 at lysine 9  in 
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the centric heterochromatin (Rea et al. 2000). The Su(var)3-9 protein has been 
shown to interact with HP1 (Schotta et al. 2002). Localization of HP1 to 
heterochromatin is dependent on Su(var)3-9 and vice versa. This indicates that 
Su(var)3-9  plays an important role in regulating heterochromatin formation  
 Su(var)3-7 is also a haplo-suppressor with a triplo-enhancer effect, and 
encodes a protein containing seven zinc fingers. It is associated with 
heterochromatic DNA, and has particular affinity for the AATAT and 353bp 
repeats (Cleard and Spierer 2001). The Su(var)3-7 protein has been shown to 
interact with the Su(var)3-9 and HP1 proteins (Cleard et al. 1997).  
 Su(var)3-3 has been identified as the drosophila homolog of the human 
LSD1 amine oxidase (Rudolph et al. 2007). Su(var)3-3 causes demethylation of 
H3K4me1 and H3K4me2. Removal of the H3K4me1 and H3K4me2 methylation 
marks is an essential step for Su(var)3-9 dependent H3K9 methylation and 
subsequent heterochromatin formation. 
 Su(var)3-6, which is allelic to PP1 gene (protein-phosphatase) at 87B, 
encodes the catalytic subunit of PP1 (Baksa et al. 1993). The Su(var)3-6 protein 
has been postulated to regulate the phosphorylation state of proteins involved in 
heterochromatin formation (Dombradi and Cohen 1992).  
 
E(var) genes 
  The protein products of E(var) genes have been implicated in 
euchromatin formation. However, Weiler and Wakimoto (2002) have suggested 
that transcriptional factors can also behave as enhancer proteins recruited by 
subsets of euchromatic genes for their normal expression. This was suggested 
by the results of molecular characterization of several E(var) genes.  For 
example E(var)3-93E, the first molecularly characterized enhancer gene, 
encodes a transcriptional activator identified as dE2F (Seum et al. 1996). It is 
also a cell-cycle regulator and its function is analogous to the mammalian E2F. 
Since dE2F is a transcriptional activator, Seum et al (1996) proposed that dE2F 
would play a role in chromatin decondensation process by acting as a positive 
regulator of a enhancer gene.  
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 E(var)3-93D (also identified as Mod(mdg4) (Dorn et al. 1993a; 
Gerasimova et al. 1995) encodes a protein that harbours the BTB/POZ  domain 
also found in other transcriptional regulators. The E(var)3-93D protein has been 
implicated in euchromatin formation by binding to the Suppressor of Hairy wing 
(Su(Hw) protein (Gerasimova et al. 1995). The  Su(Hw) protein has been shown 
to bind the gypsy insulator sequence (Spana et al. 1988). Insulators are 
regulatory elements that act as barriers to inhibit the spread of heterochromatin 
and also can disrupt important enhancer-promoter interactions (reviewed by 
Brasset and Vaury 2005).   
 The haplo-enhancer gene Trithorax-like has been shown to encode the 
GAGA transcription factor (Farkas et al. 1994). The N-terminal tamtrack motif of 
GAGA factor promotes association with other euchromatic proteins and thus 
maintains an euchromatic chromatin state. Recently it was proposed that 
expression of the w gene is maintained by GAGA factor and FACT (Nakayama et 
al. 2007). The GAGA factor and FACT mediate the recruitment of the histone 
variant H3.3 which has been implicated in inhibiting heterochromatin formation. 
   Enhancer genes that encode proteins other than transcription factors have 
also been identified. The Hel gene or (hel) is a haplodependent enhancer with a 
triplo-dependent suppressor effect (Eberl et al. 1997). It encodes a protein HEL 
that is similar to the ATP-dependent RNA helicase. Cytological studies indicate 
that the HEL protein localizes to the nucleus and is present on chromosomes 
throughout the interphase of the cell cycle (Eberl et al. 1997). The association of 
HEL protein with salivary-gland chromosomes and enhancement of PEV 
suggested that it might be involved in regulating a euchromatic structure. The 
authors proposed that HEL protein could bind RNA instead of DNA and regulate 
chromatin structure. The HEL protein might inhibit the association of mRNA at 
the transcription start site thus keeping it accessible to transcription. Alternatively 
the HEL protein could bind an RNA component of the chromosome and prevent 
heterochromatin formation. 
 Upb, which encodes the enzyme ubiquitin protease, was also identified as 
E(var)1 (Henchoz et al. 1996). The Upb mutants display a haplo-enhancer effect 
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as well as a triplo- suppressor effect on PEV. Henchoz et al proposed that Upb 
helps in maintaining a euchromatic chromatin state. The Upb protein would 
maintain the level of ubiquitinized enhancer proteins. As a result the enhancer 
proteins would not be subject to degradation and would maintain a euchromatic 
chromatin state (Henchoz et al. 1996). 
 The recently identified E(var)3-9 gene encodes a protein containing zinc-
fingers, thus suggesting that it could be a nuclei-acid binding protein (Weiler 
2007). E(var)3-9 was shown to enhance PEV of euchromatic genes but suppress 
PEV of heterochromatic genes. These experiments thus implicated a role of wild-
type E(var)3-9 product in euchromatin regulation. 
 The field of PEV has been a subject of intense research over the years 
and still continues to provide valuable insights. Molecular characterization of 
suppressor genes has revealed their involvement in heterochromatin formation 
process. On the other hand molecular characterization of enhancer genes has 
revealed that these genes encode euchromatic proteins ranging from 
transcription factors to chromatin remodeling factors to enzymes (Table 1.1). 
Dorn et al (1993b) conducted a mutagenesis screen that led to the isolation of lot 
of enhancer mutations, of which only a few have been molecularly characterized 
to date. The E(var)3-5 mutants were also isolated in the same screen. I pursued 
the identification and molecular characterization of the E(var)3-5 mutants, as a 

















Table 1.1 Enhancer genes of PEV  
 
Overview of thesis 
 The goals of my research project were to characterize mutations in and 
clone the E(var)3-5 gene. Seven E(var)3-5 mutants were gifted to our lab by Dr. 
Gene name Function PEV phenotype Cloning reference 






Haplo-enhancer Dorn et al. 1993a 
Trithorax-like Transcription factor Haplo-enhancer Farkas et al. 1994 
Zeste Transcription factor Recessive enhancer Judd 1995 
E2F Transcriptional activator Haplo-enhancer and triplo suppressor 
Seum et al. 
1996 
RPD3 Histone deacetylase Haplo-enhancer De Rubertis et al. 1996 





Hel ATP dependent RNA helicase 
Haplo-enhancer and 
triplo suppressor 
Eberl et al. 
1997 
Asx Transcription factor Haplo-enhancer Sinclair et al. 1998 
BEAF-32 Insulator-binding protein Haplo-enhancer and triplo-suppressor 
Gilbert et al. 
2006 





Haplo-enhancer Bao et al. 2007 
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Gunter Reuter. Genetic analysis using meiotic mapping of the lethal phenotype in 
our lab showed that E(var)3-5 is at map position 3-50.56 +/- 0.28 map units, 
which corresponds to cytological location 86DE (Weiler unpublished). 
Complementation tests of E(var)3-5- mutants with the deficiency stocks indicated 
that E(var)3-5 is present in the region from 86E2-4 to 87B1-5 
 My first goal was to characterize the lethality of E(var)3-5 mutations. This 
study would enable me to understand the functions of the E(var)3-5- gene 
product. I used the approach of analyzing the lethality produced by homozygous 
E(var)3-5- embryos and deficiency/E(var)3-5- embryos. If the lethality occurred 
during embryogenesis, as anticipated from preliminary experiments, I would 
analyze the terminal phenotype of unhatched embryos. These unhatched 
embryos would be observed carefully for any abnormalities in the development 
pattern. If third instar larvae were recovered, I intended to observe polytene 
chromosomes and neuroblast chromosomes. Polytene chromosomes would be 
observed to study defects in the banding pattern of the chromosomes, or 
abnormality in levels of polyteny. Neuroblast chromosomes would be observed to 
identify defects in mitosis. Chapter three describes my work to characterize the 
lethality of E(var)3-5 mutants. 
 My second goal was to identify the genetic locus on the third chromosome 
that corresponds to E(var)3-5. To identify which gene might be a potential 
candidate for E(var)3-5, I pursued the approach of  complementation tests 
analysis using deficiency stocks (deficiency mapping). Given the size of available 
deficiencies, it was anticipated that I would generate deletions within the region 
defined by a noncomplementing deficiency using FRT-bearing transgenes and 
FLP recombinase. These deletions would be used to better map E(var)3-5. 
Additionally, complementation tests would be carried out with lethals in region of 
interest to eliminate or include the possibility of that particular gene being 
E(var)3-5. After the E(var)3-5 gene was identified, transgenes would be 
generated to analyze if the transformants rescued lethality. My work to identify 
the E(var)3-5 gene is described in chapter two. Unfortunately I concluded that the 
lethality of the original mutants was not the result of mutations in a single gene. 
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As the CG17360 locus was primarily responsible for the lethality and caused 
surviving flies to have an unexpended wing phenotype, I characterized this gene. 































Chapter 2: Identification of the E(var)3-5 gene. 
 
Introduction 
Dorn et al. (1993b) carried out large-scale experiments to isolate PEV 
modifying genes that behaved as enhancers. The isolation of PEV enhancing 
gene would facilitate the understanding of, the process of chromosome 
decondensation or euchromatin formation. Classic mutagens such as X-rays, 
EMS were used. In addition the π2 P-element and modified P-elements such as 
Icarus-neo, pUChsneory+, P[lArB] were also used. The enhancer mutations were 
selected based on their ability to enhance the variegation of whitemottled4 (wm4) 
allele. A large number of enhancer mutations were isolated and it was estimated 
that around 50-60 enhancer loci exist on the second and third chromosome. 
Mutant alleles of E(var)3-5 were isolated as a dominant enhancers of variegation 
of wm4 mutation. In the π2 P-element mutagenesis screen, four recessive lethal 
alleles of E(var)3-5 were isolated on third chromosome. Similarly in the Icarus-
neo mutagenesis screen six recessive lethal alleles of E(var)3-5 were isolated. 
However the E(var)3-5 mutations did not revert in the presence of a transposase 
and none of the E(var)3-5 alleles retained an Icarus-neo homology as detected 
by Southern blot analysis of mutant lines. The same was true for E(var)3-4 
alleles, which were also isolated in the Icarus-neo mutagenesis. Dorn et al. 
(1993b) thus suggested that the mutations might be spontaneous in nature. The 
E(var)3-5 alleles were mapped on the right arm of chromosome three (Dorn et al. 
1993b) 
 Seven E(var)3-5 alleles were gifted generously to our lab by Dr. Gunter 
Reuter. Previous meiotic mapping data showed that the lethality of E(var)3-5 
mutants was located at map position 3-50.56+/- 0.28 map units, which 
corresponds to cytological location 86DE (Weiler, unpublished). 
Complementation tests of E(var)3-5  mutants with deficiency stocks indicated that 
Df(3R)cu/TM6B, Tb and Df(3R)M86D/TM3, Ser complemented, whereas 
Df(3R)M-Kx1/TM3, Sb Ser and Df(3R)T-32 cu sr e/MRS did not complement 
 
24 
(Weiler, unpublished). These data indicated that E(var)3-5 was present in region 
86E2-4 to 87B1-5. 
 I planned to map the approximate location of the E(var)3-5 gene by 
carrying out complementation tests with several Exelixis deficiencies having 
defined end-points.  Once I narrowed the approximate location, I intended to 
generate smaller deletions using the FLP-FRT system to map the E(var)3-5 
mutation to a smaller region. P elements and PBac transposons such as 
PBac{RB} and PBac{WH} would be used for making deletions. All these 
transposons contain a FRT site of 199 basepair. The FRT site is 5’ (in XP and 
WH transposons)  and is 3’ (in RB transposons) of the white+ (w+) transgene 
(Parks et al. 2004). Trans-recombination between FRT sites due to the action of 
FLP recombinase results in a genomic deletion or duplication (Figure 2.1A). 
Depending on the pair of transposons used, a deletion can be identified due to 




Figure 2.1 FLP-FRT mediated deletion generation and detection. 
The chromosomes are indicated as black lines. The two transposons are shown 
as blue and red triangles. A. Recombination between the FRT sites due to FLP 
recombinase results in a hybrid transposon, which is w- in the example shown.  
B.  The PCR strategy for identifying the deletions is illustrated, with the primers 
shown as arrows.  Two inward primers can synthesize a unique product for some 
hybrid elements (above).  Other hybrid elements are identified by the presence of 




After obtaining these deletions, I planned to carry out complementation tests of 
these deletions with E(var)3-5 mutants. Once I identified the E(var)3-5 gene 
based on its failure to complement, I intended to generate one or more 
transgenes using the appropriate DNA fragments. I planned to determine if the 
transgene would rescue the lethality and the enhancer phenotype of E(var)3-5 
mutants, which would confirm that the identified gene is E(var)3-5.  
 To study the dosage-dependent enhancer effect of the E(var)3-5 gene, I 
planned to generate a duplication that would carry three copies of E(var)3-5 gene 
using the FLP-FRT system described above. Since the function of a single wild 
type E(var)3-5+ gene is to promote euchromatin, the effect of three wild-type 
copies of E(var)3-5+ should be suppression of PEV.  
 A Northern analysis was planned to detect the expression pattern of 
E(var)3-5 transcript during different stages of development and in various tissue 
types.  
 
Materials and methods 
 
Drosophila stocks and culture conditions:  All the strains and crosses were 
maintained in cornmeal-malt medium established as a standard media recipe by 
Bloomington Drosophila Stock Center (http://flystocks.bio.indiana.edu). The 
crosses were maintained at 25°C unless otherwise noted. The E(var)3-5 mutants 
alleles were isolated by Dorn et al. (1993b) and were gifted to our lab by R. Dorn 
and G. Reuter. The Exelixis deficiencies Df(3R)Exel7310, Df(3R)Exel 6162, 
Df(3R)Exel7312, Df(3R)Exel8155 and Df(3R)Exel7313 and PBac insertion lines 
PBac{WH}glof02674, PBac{WH}CG6962f05936,  and PBac{RB}CG17360e02295 were 
obtained from Bloomington Stock Center. The P and PBac element stocks 
P{XP}l(3)neo38d03325, PBac{WH}f01607, PBac{RB}CG6950e01513, 
P{XP}CG31368d00672  and PBac{WH}CG17360f05458 were obtained from the 
Exelixis Collection at the Harvard Medical School. Information on other mutants 




Deletion generation using the FLP-FRT system:  For obtaining deletions, 
females bearing an X chromosome expressing FLP recombinase, P[ry+ hs-FLP] y 
w, and two third chromosome P or PBac element insertions containing FRT sites 
were heat shocked at 37°C for one hour for the first six days of development to 
induce expression of the FLP recombinase. The adults were then crossed to iso 
w1118 /Y; wgSp –1 /Cyo ; sens Ly-1/ TM6B, Tb males. From the resulting cross five w-  
Tb Hu males were recovered for a w- deletion, and for a w+ deletion at least 50 w+ 
Tb Hu males were recovered. The males were stocked by crossing to iso w1118; 
iso2; Dr1/TM6B, Tb Hu females. PCR analysis was done on the recovered males 
after setting up the cross to confirm the deletion. The PCR strategy is illustrated 
in Figure 2.1B. The deletion was confirmed by detecting the hybrid P or PBac 
element or by detecting the two PBac element ends, one originating from each 
original transposon. The same strategy was applied for generating a duplication. 
Table 2.1 lists the deletions and duplication and the primers used for detecting 
them. Table 2.2 lists the sequence of the primers. Four isolates were recovered 
for Df(3R)D1M1, Df(3R)D7M1, Dp(3R)D1M1. Two isolates were recovered for 
Df(3R)D5M3 and Df(3R)CG17360. One isolate was recovered each for 






















Table 2.1 PCR analyses of putative deletions and duplications 
 
aThe deletion was not obtained. 
Table 2.2 Sequence of primers used for identification of deletions and duplication 
aTransposon-specific primers directing synthesis inward; designed by Parks et al. 
(2004) 
bTransposon-specific primers directing synthesis outward; designed by Parks et 
al. (2004) 
cGenomic primers 
Deletion Deletion  type   
Left primer  Right primer  Expected 
fragment size 
Df(3R)D1M1 w- XP5’ in RB3’ in 1.7 kb 
Df(3R)D2M2  w- XP5’ in RB3’ in 1.7 kb 
Df(3R)D4M1   w- WH5’ in XP5’ in 1.8 kb 
Df(3R)D3M1a  w- RB3’ in XP5’ in 1.7 kb 
Df(3R)D5M3  w- WH5’ in XP5’ in 1.8 kb 
Df(3R)D6M1a  w+ RB3' in  WH5' in  7.3 kb 
WH5’ out f01607 R  400 bp  
Df(3R)D7M1 w+ 
WH3’ out  f02674 F 700 bp 
WH3’ out f05458 R 190 bp 
Df(3R)CG17360  w+ 
RB3’ out  CG17360 4265 R 726 bp 
Dp(3R)D1M1  w- XP5’ in WH5’ in  1.8 kb 
XP5’ ina 5’-AATGATTCGCAGTGGAAGGCT-3’ 
RB3’ ina 5’-TGCATTTGCCTTTCGCCTTAT-3’ 
WH5’ ina 5’-GACGCATGATTATCTTTTACGTGAC-3’ 
WH5’ outb 5’-TCCAAGCGGCGACTGAGATC-3’ 
WH3’ outb 5’-CCTCGATATACAGACCGATAAAAC-3’ 
RB3’ outb 5’-CCTCGATATACAGACCGATAAAAC-3’ 
f01607 Rc 5’-CTTGGATTTGACGGGCTCTTATCG-3’ 
f02674  Fc 5’-ATGTGACCAACGAAGGAATGA-3’ 
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Reversion of the PBac{RB}CG17360e02295 element:   In order to excise the 
PBac{RB}CG17360e02295 element for obtaining CG17360 revertants, male flies 
bearing PBac {RB}CG17360e02295  element and a second chromosome 
expressing PBac transposase, CyO P(tub-PBac/T), were crossed to w; TM3, Sb 
St e/TM6B, Tb Hu e females. The PBac{RB}CG17360Rev revertant males 
identified as w-  Sb were recovered and stocked. In CG17360 revertants the 
excision of 5’ end of element was detected using the primer sets CG17360 
3219F and RB5’ out (5’-TCCAAGCGGCGACTGAGATG-3’) whereas the excision 
of 3’ end was detected using the primer sets CG17360 4265R and RB3’ out.  
 In an attempt to obtain revertants in which the PBac{RB}CG17360e02295 
has excised precisely, a CG17360 revertant identified as 
PBac{RB}CG17360e02295w-  was obtained in which the w+ transgene was mutated. 
  
Stubble (Sb) variegation: Table 2.3 lists the genotype of strains tested for an 
effect on Sb variegation. Flies bearing an E(var)3-5 mutation, CG17360 mutation 
or deletion mutation balanced with TM3, Sb were crossed to w1118; DrMio/ TM3, 
P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser flies.  The resulting Sb+ Dr - males 
were crossed to T(2:3)Sbv, In(3R)Mo Sb/ TM3, Ser virgin females. The progeny 
to be assayed for variegation of the Sb gene were identified as Ser+ Dr+. A total 
of fourteen bristles per fly were scored for being Sb or wild type. The 
macrochaetes scored were the anterior and posterior sternopleurals (4), the 
humerals (4), the posterior dorso-centrals (2) and the anterior and posterior 















Table 2.3. Genotype of strains used for Sb variegation 
 
 
PCR analysis: A series of overlapping primers were produced for the coding 
region of CG17360. The primers were designed using the software Primer 3 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and were obtained from 
Invitrogen. According to Release 5.1 of the fly genome the sequence coordinates 
for CG17360 are 3R: 7,606,851..7,612,736 
(http://flybase.bio.indiana.edu/reports/FBgn0037949.html). Nucleotide 7,606,851 
was considered as position 1 for the purpose of naming the primers, so that the 
sequence coordinate for CG17360 622F corresponds to 7,607,472. The 
sequence coordinates for other CG17360 primers can be obtained similarly. The 
primer sets were CG17360 622F (5’-AACGCTTGAGTAATGTATATGGAAA-3’) 
and CG17360 1608R (5’-GAGTATGTAGCCTCCGAGTGG-3’), CG17360 1480F 
(5’-TGTGCTTCTCCTCTTGAACCA-3’) and CG17360 2457R (5’-
AACTTATCATTTCAGGCTTTTCAAACT-3’), CG17360 2327F (5’-
TTGACACACAGACTATTTCCTTCCA-3’) and CG17360 3318R (5’-
CGCAGCAACAAGCACCAG-3’), CG17360 3219F (5’- 
TGATGGTTGCTGCTGGTGTT-3’) and CG17360 4265R (5’-
GAGCCCAATATCGGAGATGC-3’), CG17360 4145F (5’-
T(2:3)Sbv, In(3R)Mo SbI/ TM3, Ser 
w1118 ; E(var)3-501/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
w1118 ; E(var)3-503 /TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
w ; Df(3R)D1M1/TM3, Sb st e 
w ; Df(3R)D2M2/TM3, Sb st e 
w ; Df(3R)D4M1/TM3, Sb st e 
w1118; Df(3R)Exel7310/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
w ; PBac {RB}CG17360e02295/TM3, Sb st e 
w ; PBac {RB}CG17360Rev/TM3, Sb st e 
w1118 ; DrMio/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser  
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CCTGCTCGAGTATGACATTTG-3’) and CG17360 5340R (5’- 
ACACAAATAATGGTTTACCGACTT-3’), CG17360 3154F 
(5’TGAGCGGTGAAGGAAGGTGT-3’) and CG17360 3978R (5’-
CGTCCCTGAGCTGGACAGA-3’), CG17360 3734F (5’-
ATTCCTCTTGGCGATGCAA-3’) and CG17360 4578R (5’-
CGGTCTGCACTATGACACCTC-3’), CG17360 4475F (5’-
AGTTGGAACTGCTGCACACG-3’) and CG17360 5349R (5’-
CGCCGAGATACACAAATAATGG-5’), CG17360 3941F (5’-
GCGATTTGTGCTCTGGTTGTCT -3’) and CG17360 4635R (5’-
AAATGCCTGCTCGGATGTG -3’). Genomic DNA was isolated from ten first 
instar homozygous E(var)3-5 larvae and from single flies of the genotype 
E(var)3-5-/D2M2 (alleles one through seven) and CantonS (Gloor et al. 1993). In 
brief, a single fly or ten larvae was mashed in 50 ul of 1X squishing buffer with 
proteinase K and incubated at 37°C for 25-30 minutes. Proteinase K was 
inactivated by heating the samples at 95°C for 1-2 minutes. For a 25 ul PCR 
reaction a 2ul volume of the DNA prep was used. 
 
Southern analysis: Genomic DNA was isolated from 50-60 flies of the six 
E(var)3-5/TM6B  stocks and Canton S/TM6B using the protocol “Purification of 
total DNA from insects using the DNeasy blood and tissue kit” from Qiagen. 
Purified DNA was digested with PstI and the equivalent of 10 flies loaded in each 
lane of an agarose gel. Following separation and transfer to a nylon membrane, 
the blot was hybridized to a DIG-labelled PCR probe synthesized using primers 
CG17360 3219F and CG17360 4265R according to the manufacturers 
instructions (Roche). 
 
Eye pigmentation assay:  The genotype of strains tested for an effect on wm4 
variegation is indicated in Table 2.4. Virgin females bearing an E(var)3-5 
mutation or deletion mutation balanced with TM6B were crossed to ru h th st pp 
cu sr Pr e ca/TM3, Sb e males. The resulting Pr e+ males were crossed to 
In(1)wm4 virgin females. The progeny to be assayed for variegation of the w gene 
were identified as Pr+ e+. All the crosses were established at 25°C. The Pr+ e+ 
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flies were aged for 5 days at 25°C and stored at  -80°C. The red eye pigment 
was measured according to the method of Ephrussi and Herold (1944). For each 
genotype, red pigment was extracted using acidified ethanol from 10 samples, 
each containing 10 heads. The samples were split into two tubes for duplicate 
processing, and optical absorbance at 480nm was recorded.   
 
Table 2.4 Genotype of strains for wm4 variegation 
 
 
Beta-galactosidase staining:  The effect of deletion Df(3R)Exel7310 and 
mutations in CG17360 was tested on variegation of the LacZ gene.  
In(3L)BL1/TM6C, Sb Tb virgin females were crossed to males bearing an 
E(var)3-5 mutation, CG17360 mutation or deletion mutation. The mutant 
chromosomes were balanced over the TM6C, Sb Tb balancer.  Beta-
galactosidase staining was performed on Tb+ larvae from the resulting cross. The 
salivary glands of Tb+ larvae were dissected and fixed in 3.7% formaldehyde for 
15 to 20 minutes at room temperature. The salivary glands were rinsed three 
times in PBS solution for 10 minutes each. Samples were incubated in a staining 
solution (10mM NaH2PO4•H2O, 150mM NaCl, 1mM MgCl2•6H2O, 3.1mM 
K4[FeII(CN)6], 3.1mM K3[FeIII(CN)6], 0.3% Triton X 100) containing 0.2% X-gal 
and incubated at 37°C overnight. After overnight incubation, the samples were 
rinsed three times in PBS for ten minutes each. The samples were mounted in 
10% glycerol, and the number of nuclei stained in each lobe was counted.   
In(1)wm4 
w ; E(var)3-501/TM6B, Tb 
w1118 ; Df(3R)D1M1/TM6B, Tb 
w1118 ; Df(3R)D2M2/TM6B, Tb 
w1118 ; Df(3R)D4M1/TM6B, Tb 
w1118 ; Df(3R)D5M3/TM6B, Tb 




Synthesis of P{w+ UAS-CG17360} construct and sequencing:  A CG17360 
DNA fragment was PCR amplified using primers CG17360 622F and CG17360 
5349R, Phusion polymerase (NEB) and genomic DNA isolated from CantonS 
flies as a template.  It was cloned into the vector pCR-Blunt (Invitrogen) and was 
sequenced. The CG17360 1480F and CG17360 1608R, CG17360 2327F and 
CG17360 2457R, CG17360 3219F and CG17360 3318R, CG17360 4145F and 
CG17360 4265R were used as sequencing primers (described in PCR analysis 
section).  After verifying that the sequence of the clone did not have any 
mutations, it was subcloned into the pP[UAST] vector as a KpnΙ and NotΙ 
restriction fragment. 
  
Generation of P{w+ UAS-CG17360} transgenic flies:  The P{w+ UAS-
CG17360} construct was injected into w1118 embryos by Rainbow Transgenic 
Flies. Eight insertions were obtained on the 2nd chromosome and eight insertions 




Deficiency mapping of E(var)3-5 lethality:  Previous work showing that 
Df(3R)M-Kx1/TM3,Sb Ser and Df(3R)T-32 cu sr e/MRS failed to complement the 
lethality of E(var)3-5 indicated that it mapped in the genomic region 86E2-4 to 
87B1-5. I carried out complementation tests between E(var)3-5 mutants and 
Exelixis deficiency mutants to map the lethality to a defined genomic locus.  In this 
experiment Deficiency/TM6B, Tb Hu males were crossed to E(var)3-5-/TM3, 
P{w+GAL4-twi.G} P{w+UAS-2xEGFP}Sb Ser female. A 25% ratio of Sb+ Hu+ adult 
E(var)3-5/deficiency progeny was expected if the mutants complemented. The 
complementation test results indicated that E(var)3-5 mutants failed to 



















































































































The number in the parentheses indicated the number of progeny scored.  
a Df(3R)6162/TM3, Sb progeny were not obtained.  
The genomic coordinates for each deficiency are as follows: 
Df(3R)Exel7310 3R:7584303..7712814.  
Df(3R)Exel6162 3R:7713466..8106805.  
Df(3R)Exel7312 3R:7803578..7905849.  
Df(3R)Exel8155 3R:7819266..7939447.  
Df(3R)Exel7313 3R:7933838..8106582.  
 
Generation of targeted deletions:  The lethality mapping data using 
Df(3R)Exel7310 indicated that E(var)3-5 maps in the 86F6-87A1 region. 
Fourteen predicted genes map to this cytological interval. To identify which of 
these fourteen gene corresponds to E(var)3-5, I generated 5 smaller deletions 
using FLP-recombinase and FRT elements. Table 2.6 indicates the P and PBac 
elements used for obtaining the deletions. Figure 2.2 highlights the number of 
genes deleted in each deficiency. Df(3R)D2M2 and Df(3R)D4M1 together delete 




Table 2.6 P and PBac elements used for obtaining deletions 
 
 
The genomic coordinates for each deficiency are listed below 
Df(3R)D1M1 3R:7604127..7611052.  
Df(3R)D2M2 3R: 7604127..7647966.  
Df(3R)D4M1 3R: 7644087..7712923.  
Df(3R)D5M3 3R: 7708215..7712923.  
Df(3R)D7M1 3R: 7634175..7644087.  
Df(3R)CG17360 3R: 7606891..7611052. 
 
Figure 2.2 FLP-FRT mediated targeted deletions in Df(3R)Exel7310 region 
The genes defined by the Df(3R)Exel7310 region are listed in the first column. 
The genes deleted in each deficiency are indicated.  
 
Deletion Proximal P element 
Distal P 
element 
Df(3R)D1M1 P{XP}l(3)neo38d03325 PBac{RB}CG17360e02295 
Df(3R)D2M2 P{XP}l(3)neo38d03325 PBac{RB}CG6950e01513 
Df(3R)D4M1 PBac{WH}glof02674 P{XP}CG31368d00672 
Df(3R)D5M3 PBac{WH}CG6962f05936 P{XP}CG31368d00672 
Df(3R)D7M1 PBac{WH}f01607 PBac{WH}glof02674 
Df(3R)CG17360 PBac{WH}CG17360f05458 PBac{RB}CG17360e02295 
Lk6      
l(3)neo38    
CG17360 
Df(3R)D1M1 
   
HisC     
Sbf     
CG31116    
CG6946   
Df(3R)D7M1 








CG6959     
Sad     
CG6962    
CG31368    






Complementation test of E(var)3-5 mutants with targeted deletions:   I 
carried out complementation tests between E(var)3-5 mutants and deletion 
mutants to identify the gene that might be allelic to E(var)3-5. A 33% ratio of Sb+ 
flies was expected if the two mutants complemented each other. The 
complementation tests were set up in vials. The results are shown in Table 2.7. 
The complementation test results indicated that Df(3R)D4M1, Df(3R)D5M3 and 
Df(3R)D7M1 complement the lethality of E(var)3-5 mutants. With Df(3R)D1M1 
and Df(3R)D2M2, Sb+ progeny were obtained but the percentage was low 
(except for Df(3R)DIMI line 3), which indicated that E(var)3-5 mutants fail to 
complement these deficiencies. 
  Df(3R)D1M1 and Df(3R)D2M2 delete two genes, CG17360 and 
l(3)neo38. To identify which of these genes might be allelic to E(var)3-5, I carried 
out complementation tests of  PBac{RB}CG17360e02295 and mwh l(3)neo38 red e 
mutant  females with E(var)3-501 mutant males. The complementation tests were 
set up in vials.  A 33% ratio of Sb+ flies was expected if the two mutants 
complemented each other. The results are indicated in Table 2.8. After 
performing the tests I discovered that the l(3)neo38 mutants do not have a 
recessive lethal phenotype and the flies of the stock were Sb+. Therefore, 
l(3)neo38 is not allelic to E(var)3-5. These results pointed out that CG17360 
might be allelic to E(var)3-5. However the ratio of of Sb+ progeny (25.6%) was 
only slightly lower than expected (Table 2.8). I repeated the complementation 
test between PBac{RB}CG17360e02295 and E(var)3-5 mutant alleles and a 
consistent number of E(var)3-5-/PBac{RB)CG17360e02295 Sb+ progeny was not 













Table 2.7 Complementation test of E(var)3-5 mutants and deletion mutants 
 
The E(var)3-5 mutant alleles and deletion alleles were balanced over the TM3, 
Sb balancer. This data was derived from one experiment. The tests were set up 
in vials.   
* The flies had unexpanded wings.  
 
Table 2.8 Complementation test of E(var)3-501 mutant allele 
 
E(var)3-501  males 
 Females 
 
Trial Sb Sb+ Total  
l(3)neo38 1 36  (41.8%) 50 (58.1%) 86 
 2   145 (37.6%)     240  (62.3%) 385 
PBac{RB}CG17360e02295 1   122 (74.3%) 42  (25.6%)∗ 162 
The chromosomes in mutant alleles were balanced over the TM3, Sb balancer. 
The complementation tests were carried out in vials.  





                                           Females 
Males 
E(var)3-501 E(var)3-503 
 Sb Sb+ Sb Sb+ 
Df(3R)D1M1 isolate 1 64 (91.4% ) 6 (8.5%)* 118 (90.7%) 12 (9.2%)* 
Df(3R)D1M1 isolate 2 58  (96.6%) 2  (3.3%)* 71 (85.5%) 12 (14.4%)* 
Df(3R)D1M1 isolate 3 97  (75.1%) 32 (24.8%)* 117 (88.6%) 15 (11.3%)* 
Df(3R)D1M1 isolate 4 79  (98.7%) 1 (1.2%)* 65 (94.2%) 4 (5.7%)* 
Df(3R)D2M2  143 (90.5%) 15 (9.4%)* 109 (97.3%) 3(2.6%)* 
Df(3R)D4M1 108 (61.3%) 68 (38.6%) 116(55.2%) 94 (44.7%) 
Df(3R)D5M3 67  (60.3%) 44 (39.6%) 12(58.7%) 87(41.2%) 
Df(3R)D7M1 isolate 4 93  (62.4%) 56  (37.5%) 102 (60.7%) 66 (39.2%) 
Df(3R)D7M1 isolate 
26 90 (58.4%) 64 (41.5%) 88 (67.1%) 43 (32.8%) 
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Females  Sb ∗ Sb+ Sb ∗ Sb+ Sb ∗ Sb+ 
215 11 244 1 - - PBac{RB} 
CG17360e02295 1 95.1% 4.8% 99.5% 0.4%   
145 44 204 27 - - 
 2 
76.7% 23.2% 88.3% 11.6%   
- - - - 188 5 
E(var)3-501 1 
    97.4% 2.5% 
- - - - 133 36  
2 
    78.6% 21.3% 
- - - - 220 3 
E(var)3-503 1 
    98.6% 1.3% 
- - - - 108 22  
2 
    (83.0) 16.9% 
The chromosomes in mutant alleles were balanced over the TM3, Sb balancer. 
The numbers in the brackets indicate the % of Sb and Sb+ progeny.  
∗ The Sb+ flies had unexpanded wings. 
 
 In addition, E(var)3-5/Df(3R)D1M1 and E(var)3-5/Df(3R)D2M2 flies were 
found to have an unexpanded wing phenotype. E(var)3-5-/ 
PBac{RB}CG17360e02295 flies also exhibited an unexpanded wing phenotype. In 
order to verify that this phenotype was linked to the PBac insertion in CG17360, I 
generated revertant alleles of PBac{RB}CG17360e02295  and carried out 
complementation tests with the E(var)3-5 mutant alleles. The purpose of this 
experiment was to determine whether the revertant allele restores the wing 
phenotype, and to verify that the reduction in viability observed for 
PBac{RB}CG17360e02295/E(var)3-5- flies was due to the CG17360 insertion 
mutation.  The results are shown in Table 2.10. The results indicated that 
E(var)3-501/ PBac{RB}CG17360Rev and E(var)3-503/ PBac{RB}CG17360Rev had a 
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wild-type wing phenotype. Similarly, in 
PBac{RB}CG17360Rev/PBac{RB}CG17360e02295 and 
PBac{RB}CG17360Rev/PBac{RB}CG17360e02295w-  flies the wing phenotype was 
wild-type indicating that one wild-type copy of CG17360 is essential for obtaining 
normal wings.  The PBac{RB}CG17360Rev/E(var)3-5- flies were observed at the 
expected frequency (38.9% and 34.3%), showing that mutation of CG17360 
caused the reduction in viability.  However, there appeared to be additional 
mutations on the PBac{RB}CG17360e02295 chromosome that slightly reduced 
viability when this chromosome was homozygous (e.g. 
PBac{RB}CG17360Rev/PBac{RB}CG17360Rev 
 








Males Sb Sb+ Sb Sb+ Sb Sb+ 
110 25∗ 369 232 379 73∗ 
E(var)3-501 
81.4% 18.5% 60.9% 38.9% 83.8% 16.1% 
61 22∗ 412 216 366 14∗ 
E(var)3-503 
73.4% 26.5% 65.6% 34.3% 96.2% 3.6% 
185 39 328 116 470 102 PBac{RB} 
CG17360Rev 82.5% 17.4% 73.8% 26.1% 82.1% 17.8% 
137 11 394 204 355 33 
Df(3R)D1M1 
92.5% 7.4% 65.8% 34.1% 91.4% 8.5% 
89 12 437 210 235 23 
Df(3R)D2M2 
88.1% 11.8% 68.4% 31.5% 93.5% 6.4% 
33 9 327 67 412 19 PBac{RB} 
CG17360e02295w- 78.5% 21.4% 82.9% 17% 95.6% 4.4% 
The chromosomes in mutant alleles and the revertant allele were balanced over 
the TM3, Sb balancer. The data derived from a single experiment. 




 The PBac{RB}CG17360e02295 insertion in CG17360 may not eliminate the 
function of CG17360 and this could be why the PBac{RB}CG17360e02295 mutants 
partially complement E(var)3-5 mutants. I therefore generated a null allele of 
CG17360 by deleting coding sequence of CG17360 using the FLP-FRT 
mediated technique. Two isolates were obtained, Df(3R)CG17360M28 and 
Df(3R)CG17360M56. I carried out complementation tests of Df(3R)CG17360M56 
mutant alleles. A 33.3% ratio of Sb+ progeny was expected if the mutants 
complemented. The complementation tests were performed in vials. Also it was 
learned that Df(3R)CG17360M56/TM3, Sb st e flies had an unexpanded wing 
phenotype. Thus all mutant alleles had to be balanced over the TM6C, Sb Tb 
balancer. The complementation test results indicated that a null allele of 
CG17360 partially complements E(var)3-5 (ratio of Sb+ progeny, 16.3% and 
18.2%).(Table 2.11). A low ratio of Sb+ progeny (12.1%) was obtained with 
PBac{RB}CG17360e02295 flies. Also a low ratio of Sb+ progeny (12%) representing 
the genotype Df(3R)D1M1/ Df(3R)CG17360M56 was obtained when two deletion 
mutants were crossed to each-other.  
 
Table 2.11 Complementation tests of Df(3R)CG17360M56 mutant allele in vials 
 
Males Df(3R)CG17360M56 females 
 Sb Sb+ Total 
E(var)3-501 556 (83.5%) 109 (16.3%)* 665 
E(var)3-503 665 (81.7%) 148  (18.2%)* 813 
PBac{RB}CG17360Rev 774 (71.9 %) 300 (27.9%) 1074 
Df(3R)D1M1 808  (87.8%) 111 (12.0%)* 919 
PBac{RB}CG17360e02295 802 (87.8%) 111 (12.1%)* 913 
The CG17360, E(var)3-5 and CG17360Rev mutant chromosomes were balanced 
over the TM6C, Sb Tb balancer. The number in the parenthesis indicates the % 
of Sb and Sb+ progeny. The complementation tests were carried out in vials. The 
PBac{RB} CG17360Rev was used as control. The data was derived from a single 
experiment.  
*The flies had unexpanded wing phenotype.  
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To determine if the variability in results (frequency of Sb+) might be related 
to the high-density growth conditions in vials, I repeated complementation test 
done in bottles. The results for complementation test of Df(3R)CG17360M56 
mutant allele done in bottles is shown in Table 2.12. The complementation test 
indicated that Df(3R)CG17360M56 mutant allele complement E(var)3-5 mutants 
alleles since the expected ratio of Sb+ progeny was obtained (Table 2.12). 
Overall the results of complementation tests done in bottles and vials indicated 
“differences” in ratio of Sb+ progeny obtained. Variability in the ratio of Sb+ 
progeny was observed with complementation tests in vials. These results 
suggested that Sb+ progeny representing genotypes E(var)3-5-/CG17360- and 
E(var)3-5-/Df(3R)D1M1 were sensitive to density conditions in bottles versus 
vials. 
  
Table 2.12 Complementation test of Df(3R)CG17360M56 mutant allele in bottles 
 
The chromosomes of all the mutant alleles were balanced over the TM6C, Sb Tb 
balancer. The number in the brackets indicates the % of Sb and Sb+ progeny. 
The PBac{RB}CG17360Rev was used a control. * indicates unexpanded wings.  
 Df(3R)CG17360M56 females 
Males Trial Sb progeny Sb+ progeny Total 
E(var)3-501 1 408  (65.9%) 205  (33.9%)* 613 
 2 564  (70.7%) 233  (29.2%)* 797 
E(var)3-503 1 298  (64.1%) 166  (35.7%)* 464 
 2 346  (62.8% ) 204  (37%)* 550 
PBac{RB}CG17360Rev 1 446  (66.8%) 222  (33.2%) 668 
 2 774  (71.9%) 300  (27.9%) 1074 
Df(3R)D1M1 1 544  ( 75.9%) 172  (24.0%)* 716 
 2 565  (78.1%) 158  (21.8%)* 723 
PBac{RB}CG17360e02295 1 489  (77.9%) 138  (22%)* 627 




As these results indicate that the lethality of E(var)3-5- mutations does not 
map to CG17360, I repeated my complementation tests of E(var)3-501 and 
E(var)3-503 mutant alleles with Df(3R)Exel7310, the FLP-FRT deletion alleles and 
the PBac{RB}CG17360e02295 allele in bottles.  This experiment repeated crosses 
shown in Tables 2.5 and 2.7, but was designed to get an estimate of Sb+ progeny 
under low density culture conditions. The results for the complementation tests 
are shown in Tables 2.13 and 2.14. The results showed an increase the recovery 
of Sb+ progeny for the Df(3R)D1M1 and Df(3R)D2M2 crosses as compared to 
the results obtained when crosses were performed in vials, indicating that culture 
density affected the results.  However, the fraction of Sb+ progeny for 
Df(3R)D1M1, Df(3R)D2M2 and PBac{RB}CG17360e02295 was still slightly below 
that obtained for Df(3R)D4M1 and Df(3R)Exel9019, suggesting that mutation of 
CG17360 does decrease viability even under low density culture conditions.  
Interestingly, the E(var)3-5- alleles still failed to complement Df(3R)Exel7310.  
This result is curious because the other deficiencies together remove the entire 
region deleted by Df(3R)Exel7310.   
 
Table 2.13 Complementation test of E(var)3-501mutant allele 
 
The chromosomes of all the mutant alleles were balanced over the TM3 
balancer. The data was derived from single experiment. Df(3R)Exel9019 deletes 
Lk6. 
* The Sb+ flies had unexpanded wings. 
E(var)3-501 females  
Males Sb progeny Sb+ progeny Total 
Df(3R)D1M1 226   (71.7%)  89    (28.2%) * 315 
Df(3R)D2M2 282   (67.5%)  135   (32.3%) * 417 
Df(3R)D4M1 243  (59.4%)  166    (40.5%) 409 
Df(3R)Exel9019 504   (60.9%) 323      (39%)  827 
Df(3R)Exel7310 298   (98%)  6        (2%) * 304 
PBac{RB}CG17360e02295 234  (71.4%)  93      (28.4%)* 327 
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Table 2.14 Complementation test of E(var)3-503 mutant allele 
 
The chromosomes of all the mutant alleles were balanced over the TM3 
balancer. The data was derived from a single experiment.  
* The Sb+ flies had unexpended wings 
 
Complementation test of the E(var)3-507 mutant allele:   The E(var)3-507 
mutant allele was isolated in a π2 mutagenesis screen. I carried out a 
complementation test of the E(var)3-507 mutant allele with  Df(3R)Exel7310 and 
Df(3R)D1M1 mutants. A 33% ratio of Sb+ progeny was expected if the mutants 
complemented. The results are indicated in Table 2.15. The complementation 
test results indicated that the lethality of the E(var)3-507 mutant did not 
complement the lethality of the Df(3R)Exel7310 mutant allele. However the 
E(var)3-507 mutant partially complemented Df(3R)D1M1, similar to the results 









E(var)3-503 females  
        Males Sb progeny Sb+ progeny Total 
Df(3R)D1M1 613   (77%) 182   (22.8%)* 795  
Df(3R)D2M2 749   (81.3%) 171   (18.5%)* 920 
Df(3R)D4M1 199   (65.8%) 103   (34.1%) 302 
Df(3R)Exel9019 653   (65.1%) 349   (34.8%) 1002 
Df(3R)Exel7310 498   (99%) 5   (1%)* 503 
PBac{RB}CG17360e02295 585  (75.2%) 192   (24.7%)* 777 
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Table 2.15 Complementation test of E(var)3-507 mutant allele 
 




Sb Sb+ Total progeny scored 
Df(3R)Exel7310 43  (%) 0  (%) 43 
Df(3R)D1M1 62  (%) 22  (%)* 84 
The mutant chromosomes were balanced over the TM3, Sb balancer. The data 
was derived from single trial. The complementation tests were set up in vials. 
* Sb+ flies had unexpanded wing phenotype.  
 
Complementation test of the E(var)3-409 mutant allele:   Six of the E(var)3-5 
alleles were isolated in the Icarus-neo mutagenesis. The E(var)3-409 allele was 
also identified in the Icarus-neo screen. I carried out complementation tests 
between E(var)3-501 females and E(var)3-409  males to determine if 
complementation occurs between these mutant alleles. A 25% ratio was 
expected if the mutants complemented each other. The results are indicated in 
Table 2.16. Since a 25% ratio of Sb+ Cy+ was not obtained, the complementation 
test results indicated that the lethality of the E(var)3-501 mutant did not 
complement the lethality of the E(var)3-409 mutant allele. In addition, the 
unexpanded wing phenotype of the few E(var)3-501/E(var)3-409 progeny 
suggested that the chromosomes share mutations in CG17360. 
 
Table 2.16 Complementation test of E(var)3-409 mutant allele 
  
The mutant E(var)3-501 chromosome was balanced over theTM3, P{w+GAL4-
twi.G}, P{w+UAS-2xEGFP}, Sb Ser balancer. The Sb+ Cy+ progeny represent the 
genotype E(var)3-501/E(var)3-409. The complementation tests were done in vials. 




E(var)3-501 females  
Males 
 Sb
+ Cy+  Sb+ Cy Sb Cy+ Sb Cy Total  
ItG10; E(var)3-409/ 










PCR analysis of CG17360 in E(var)3-5- mutant alleles:   Complementation test 
analysis between E(var)3-5 mutants and CG17360  mutants yielded E(var)3-5-/ 
CG17360- progeny that exhibited an unexpanded wing phenotype. These results 
indicated that E(var)3-5 mutants might harbor mutations in the CG17360 gene. 
PCR analysis of the CG17360 gene was performed for E(var)3-5 alleles. DNA 
obtained from homozygous E(var)3-5 mutants or Df(3R)D2M2/E(var)3-5-  flies 
was used to amplify the coding region of CG17360 using the primer sets 
described in Materials and Methods. DNA obtained from CantonS flies was used 
as a positive control. The PCR results are listed in Table 2.17 and illustrated in 
Figure 2.3. The results indicated that initially a 1064 bp region and a 844 bp 
region could not be amplified by primers sets 3219F-4265R and 3734F-4578R 
respectively. This suggested that mutations exist in the genomic region defined 
by 3219F and 4578R. Further narrowing down the region of  mutation, indicated 
that a 433 bp and a 324 bp region could not be amplified by primer sets 4145F-
4578R and 3941F-4265R respectively. As the primer combination 4145F-4265R 
was not a good combination, analyses could not be performed using this primer 
set.  However, the other results suggest that the block to PCR amplification maps 
to the 4145-4265 region. Overall the result indicated that CG17360 harbors 























622F-1608R E(var)3-501 986 bp 986 bp 
1480F-2457R E(var)3-501 977 bp faint band of 977 bp 
2327F-3318R E(var)3-501 991bp 991bp band 
3154F-3978R Alleles 01-06 825bp 825bp band 
3219F-4265R Alleles 01-06 1046bp DNA band not observed 
3734F-4578R Alleles 01-06 844bp DNA band not observed 
3941F-4265R Alleles 01-06 324bp DNA band not observed 
2327F-4265R E(var)3-501 1938bp DNA band not observed 
4145F-4578R Alleles 01-06 433bp DNA band not observed 
4475F-5349R E(var)3-501 875bp 875bp DNA band observed 
The expected DNA bands were observed using Canton S DNA. 
 
Figure 2.3 PCR analysis of CG17360 in E(var)3-5- allele 
 
 
The CG17360 transcription unit is shown as black arrow in 5’ to 3’ direction. The 
forward and reverse arrowheads represent the forward and reverse primers 
respectively. Black lines indicate that a PCR product was formed. The broken 
lines indicated that PCR product was not formed. The primer combinations 
indicated in the figure are as follows:  1 = 622F-1608R; 2 = 1480F- 2457R; 3 = 
2327F-3318R; 4 = 3154F-3978R; 5 = 4475F-5349R; 6= 2327F-4265R; a = 




PCR analysis of CG17360 in the E(var)3-507 mutant strain:  The E(var)3-507 
allele was isolated in a π2 P-element mutagenesis screen, a different screen than 
that used for the isolation of the six E(var)3-5 alleles. PCR analysis of the 
CG17360 coding gene sequence region was done for the E(var)3-507 strain to 
determine the presence of mutations. Genomic DNA was isolated from E(var)3-
507/Df(3R)D1M1 flies and was subjected to PCR analysis. The results are 
indicated in Table 2.18. Similar results like that observed for six E(var)3-5 alleles 
were observed for E(var)3-507 indicating that the genomic region between 3941F- 
4265R harbors mutations. 
  
Table 2.18 PCR analysis of CG17360 in E(var)3-507 mutant allele 
 
Primers sets used Expected DNA band Observed results 




977 bp faint band of 977 bp observed 
2327F-3318R 
 
991bp 991bp DNA band observed 
3154F-3978R 
 
825bp 825bp DNA band observed 
3219F-4265R 
 
1046bp Expected DNA band not observed  
3734F-4578Ra 
 
844bp Expected DNA band not observed 
3734F-4265R 531bp Expected DNA band not observed 
3941F-4265R 324bp Expected DNA band not observed 
4475F-5349R 
 
875bp 875bp DNA band observed 
622F-5349Ra 4727bp Expected DNA band not observed 
3734F-5349Rb 1615bp Expected DNA band not observed 
The expected DNA bands were observed using Canton S DNA that was used as 
positive control.  
a PCR was done using DNAzyme polymerase.  




PCR analysis of CG17360 in the E(var)3-409 mutant:  PCR analysis was done 
for the E(var)3-409 mutant allele to determine if its failure to complement E(var)3-
501 was due to the same mutation in CG17360. DNA was isolated from E(var)3-
409/Df(3R)D1M1 flies and was analyzed by PCR using the primer sets 3734F-
4578R. DNA isolated from Canton S flies was used as a positive control. The 
results revealed that the primers could not amplify the expected 844bp DNA 
band in E(var)3-409/Df(3R)D1M1 DNA as opposed to CantonS DNA. The same 
primer set could not amplify the 844bp region in the E(var)3-5 alleles. This 
indicated that the E(var)3-4- mutant also harbored a mutation in the CG17360 
gene in the same region. 
 
Southern analysis of E(var)3-5 alleles:  A Southern blot experiment was 
performed on six E(var)3-5 alleles to analyze the nature of the mutations 
detected by PCR, and is shown in Figure 2.4B. PstI digested E(var)3-5 and 
Canton S DNA was probed with a 1064bp DNA fragment. The probe recognized 
1.0 kb and 1.9 kb DNA fragments in control Canton S DNA (Figure 2.4A).  It was 
hypothesized that the mutation preventing PCR amplification of region 3941F-
4265R might be an insertion. The mutation would disrupt a PstI fragment in the 
E(var)3-5 alleles as a result the expected 1.0 kb and 1.9 kb DNA bands would 
not be observed. The Southern analysis results are shown in Figure 2.4B. As 
expected, two DNA bands of 1.0 kb and 1.9 kb are recognized by the probe in 
the control Canton S DNA. However in all the six E(var)3-5 alleles, DNA bands of 
1.0 kb and 1.9 kb were also obtained and no unique bands were observed. This 
suggested that all the six E(var)3-5 alleles carry similar mutations. Also a 4 kb 















The PstI restriction enzyme map of CG17360 is illustrated in A. The central PstI 
site is at the genomic coordinate 3R: 7,610,846.  The genomic region defined by 
3219F and 4265R could not be amplified by PCR for the E(var)3-5 mutants. The 
probe was generated using primers 3219F and 4265R.  The results of Southern 
analysis using the probe indicated in A are shown in B.  Lane 1: CantonS DNA, 
used as positive control.  Lanes 2-7: E(var)3-5 alleles 01-06. The wild type and 
E(var)3-5 alleles were balanced using the TM3 balancer.    
 
Mapping the enhancer effect of the E(var)3-5 mutation:   The effect of 
deletions Df(3R)D1M1, Df(3R)D2M2, Df(3R)D4M1, Df(3R)D5M1 and 
Df(3R)Exel7310 was tested on variegation of the wm4 variegating allele to 
determine whether the enhancer phenotype of E(var)3-5 mutants maps in the 
86F6-87A1 region. In(wm4) females were crossed with males bearing an E(var)3-
5 mutation or deficiency mutation. Df(3R)D7M1 mutants and 
PBac{RB}CG17360e02295 mutants  were not used in the assay since these 
mutants have a red eye phenotype and the wm4 variegation assay can only be 
done on mutants having a white eye phenotype. The results for the wm4 




Df(3R)D1M1/+ revealed that these flies exhibited enhanced wm4 variegation. 
However the pigment assay revealed that Df(3R)D1M1 did not enhance wm4 
variegation. Also in the first trial In(wm4)/w ; Df(3R)D2M2/+ showed lower 
absorbance values than rest of deficiencies. However the results were not 
repeatable in the second trial and any conclusive results could not be established 
from the wm4 variegation assay.  
 
Table 2.19 Effect of deficiency mutants on In(1)wm4 variegation 
 
aFlies bearing the E(var)3-501 mutation were used as control. 
bRed eye pigment was extracted from one sample containing 10 heads and the 
average absorbance from 10 samples per genotype is shown.  
cAverage absorbance from six samples, each sample contained 10 heads. ± 
Standard-deviation 
 
  The effect of deletions Df(3R)D1M1, Df(3R)D2M2, Df(3R)D4M1 and 
Df(3R)Exel7310 was tested on variegation of the Sb gene to determine whether 
the enhancer phenotype of E(var)3-5 mutants maps in the 86F6-87A1 region. 
The T(2:3)Sbv stock that translocates the Stubble (Sb) gene containing a Sb1 
mutation near second chromosome heterochromatin was used. As a result of the 
translocation, heterochromatin-mediated inactivation of the Sb1 allele results in a 
wild-type bristle, whereas normal expression results in a short bristle. The 
T(2:3)Sbv flies thus have a combination of wild-type and Sb bristles. A mutation in 
an enhancer gene results in a decrease in the number of Sb bristles whereas a 
Genotype of females Average absorbance at 480nmb 
 Trial 1 Trial 2 
In(1)wm4/w; E(var)3-501/+a 0.010±0.004  0.008±0.002c 
In(1)wm4/w;Df(3R)Exel7310/+ 0.060±0.017 0.060±0/017 
In(1)wm4/w; Df(3R)D1M1/+ 0.050±0.014 0.040±0.014 
In(1)wm4/w; Df(3R)D2M2/+ 0.030±0.007 0.060±0.031 
In(1)wm4/w; Df(3R)D4M1/+ 0.070±0.028 0.060±0.016 
In(1)wm4/w; Df(3R)D5M3/+ 0.040±0.006 0.050±0.014 
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mutation in a suppressor gene increases the number of Sb bristles (Sinclair et al. 
1983). In this experiment T(2:3)SbV females were crossed to males bearing an 
E(var)3-5 mutation or a deletion mutation. Fourteen macrocheates in T(2:3)SbV/ 
E(var)3-5 and T(2:3)SbV/deletion flies were scored for being Sb or wild-type. The 
average number of Sb bristles for each genotype is listed in Table 2.20. The 
PBac{RB}CG17360Rev  allele was used as an internal control since it represented 
a wild-type 3rd chromosome isogenic with the deficiency chromosomes. No 
parental stock is available for the E(var)3-5 mutants. The results indicated that in 
females, E(var)3-501and E(var)3-503 significantly enhanced Sb variegation. 
Df(3R)D4M1 significantly enhanced Sb variegation suggesting that an enhancer 
phenotype maps in the region deleted by Df(3R)D4M1. In males, as expected 
E(var)3-501and E(var)3-503 significantly enhanced Sb variegation. However, 
enhancement in Sb variegation in Df(3R)D4M1 was not significantly different in 
males. I also determined the effect of mutations in the CG17360 gene on Sb 
variegation. The average number of Sb bristles for each mutant is shown in 
Table 2.21.  PBac{RB}CG17360Rev allele was used as a control. CG17360 
mutants did not enhance Sb variegation.  






















Table 2.20 Effect of deficiency mutants on Sb variegation 
 
Statistical analysis was performed separately for males and females, using one 
way ANOVA. Those genotypes statistically different (P<0.001) from the control 
PBac{RB}CG17360Rev/ T(2:3)SbV strain are indicated by **. The results for 
deficiency Df(3R)D4M1 differed in males and females. Data were derived from a 
single trial.  
 
Table 2.21 Effect of CG17360 mutant alleles on Sb variegation 
Statistical analysis was performed, using one way ANOVA. Those genotypes 
statistically different (P<0.001) from the control PBac{RB}CG17360Rev/ T(2:3)SbV 
strain are indicated by **. 
  
 
Genotype Females counted 
Average 
number of 







Sb bristles in 
males 
PBac{RB}CG17360Rev/T(2:3)SbV 42 10.4 44 9.9 
E(var)3-501/T(2:3)SbV 41 3** 39 4.2** 
E(var)3-503/T(2:3)SbV 33 2.8** 20 3.5** 
Df(3R)Exel7310/ T(2:3)SbV 36 10.2 41 10.6 
Df(3R)D1M1/ T(2:3)SbV 66 10.3 67 9.7 
Df(3R)D2M2/ T(2:3)SbV 35 10.2 48 9.7 
Df(3R)D4M1/T(2:3)SbV 39 8** 35 9.4 
 Trial 1 Trial 2 













PBac{RB}CG17360Rev/T(2:3)SbV 20 9.5 31 9.2 
E(var)3-501/T(2:3)SbV 29 3.3** 24 4.3** 
E(var)3-503/T(2:3)SbV 14 4** 30 3.8** 
PBac{RB}CG17360e02295/T(2:3)SbV 17 10.5 41 10.4 
Df(3R)D1M1/T(2:3)SbV 42 10.1 30 10.1 
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The effect of the Df(3R)Exel7310 deletion and CG17360 mutants was 
tested on variegation of the LacZ gene to detect the presence of enhancer in the 
region defined by  Df(3R)Exel7310. In(3L)BL1 females containing a single 
insertion of P[w+ hs-lacZ] transgene positioned near heterochromatin due to 
inversion were crossed to males containing a mutation in E(var)3-5 or CG17360, 
or Df(3R)Exel7310 or PBac{RB}CG17360Rev control chromosome. Salivary 
glands of mutant larvae of appropriate genotype were dissected and stained to 
analyze the expression of the LacZ transgene. Results are shown in Table 2.22 
and 2.23. The results indicated that like E(var)3-501, Df(3R)Exel7310 mutants 
enhanced LacZ variegation indicating the presence of an enhancer in the region 
deleted by this deficiency. The PBac{RB}CG17360e02295 and 
PBac{RB}CG17360M56mutants however did not enhance LacZ variegation. In 
one experiment the sex of Df(3R)Exel7310 and E(var)3-5 larvae was noted, but a 
lot of inconsistency in staining of nuclei was observed (data not shown). 
 
Table 2.22 Effect of Df(3R)Exel7310 mutants on LacZ variegation 
 
Statistical analysis was done using one-way ANOVA. Df(3R)Exel7310 and 
E(var)3-501 were not significantly different from each other (P>0.05). Data 







Genotype Trial Number of lobes counted 
Average nuclei stained 
(± standard deviation) 
In(3L)BL1/Df(3R)Exel7310 1 22 10.1± 6.8 
 
 2 13 9.3± 5.6 
In(3L)BL1/E(var)3-501 1 16 9.5± 3.5 
 2 15 8.1± 5 
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Table 2.23 Effect of CG17360 mutants on LacZ variegation 
 
Genotype Trial Number of lobes 
counted 
Average nuclei 




1 20 11.2±5.5 
 2 14 10.4±7.7 
In(3L)BL1/E(var)3-503 1 31 8.0±5.3 
 2 13 7.7±6.3 
In(3L)BL1/PBac{RB}CG17360Rev 1 25 14.6±6.2 
 2 17 19.4±7.8 
In(3L)BL1/PBac{RB}CG17360e02295 1 41 19.2±8.0 
 2 20 24.2±7.1 
In(3L)BL1/Df(3R)CG17360M56 1 36 20.3±7.3 
 2 15 19.6±6.4 
The PBac{RB}CG17360Rev chromosome was used a control. Statistical analysis 
was done using one-way ANOVA. The E(var)3-501 and E(var)3-503 enhanced 
LacZ variegation (P<0.001) compared to PBac{RB}CG17360e02295 and 
Df(3R)CG17360 M56  mutants. Data derived from two trials. Sex of the larvae was 
not determined.  
 
 Sequencing a CG17360 clone:  A DNA fragment containing the CG17360 gene 
was obtained from Canton S genomic DNA that was PCR amplified using 
primers CG17360 622F and CG17360 5349R, and cloned into vector pCR-Blunt 
(Invitrogen). Sequencing of CG17360 clones revealed a single nucleotide 
polymorphism in the region defined by CG17360 3219F and CG17360 4265R. 
The change however did not alter the coding sequence of CG17360.  
 
Over-expression analysis of CG17360:  The CG17360 gene was cloned into 
the pUAST transformation vector in order to create a rescue construct for 
analysis of CG17360.  Prior to determining, whether transgene could 
complement CG17360 mutations or influence PEV, control experiments were 
 
54 
performed to examine the effects of ectopic CG17360 expression.  I used 
different GAL4 drivers to determine whether over-expression of CG17360 affects 
viability or results in any abnormal phenotype in flies. For this experiment yw; 
P{w+; Act5C-Gal4}25FOI/CyO and w; P{w+ Hsp70-Gal4}/CyO virgin females were 
crossed to P{w+ UAS-CG17360}/CyO males bearing the CG17360 transgene 
(lines # 123, 41B, 66B). A ratio of 33% Cy+ progeny representing the genotype 
P{w+; Act5C-Gal4}25FOI/P{w+ UAS-CG17360} or P{w+ Hsp70-Gal4}/P{w+ UAS-
CG17360} was expected if over-expression did not affect viability. The results are 
indicated in Table 2.24. The results indicated that over-expression of CG17360 
did not affect viability since the expected ratio of the Cy+ flies was observed and 
any abnormal phenotype in these flies was not detected. 
 
Table 2.24 Analysis of over-expression of CG17360 
 
yw; P{w+; Act5C-
Gal4}25F01/ CyO females 












57 (40.7%) 83 (59.2%) 39 (35.4%) 71(64.5%) 
P{w+ UAS-
CG17360 }#66B   
(homozygous) 
44 (43.1%) 58 (56.8%) 78 (54.5%) 65 (45.4%) 
 
Rescue of the unexpanded wing phenotype by the UAS-CG17360 
transgene:  Previous experiments have shown that CG17360- mutants and 
E(var)3-5/CG17360-  mutants have unexpanded wings. This experiment was 
performed to determine whether CG17360 transgene rescued the wing 
phenotype. A positive result would mean that the transgene was expressed and 
functional.  In this experiment females bearing the Act5C-Gal4 transgene on the 
second chromosome and bearing a CG17360 mutation on the third chromosome 
were mated with males containing the UAS-CG17360 transgene on the second 
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chromosome and bearing an E(var)3-5 mutation on the third chromosome. The 
results are shown in Table 2.25. It was expected that the Cy Sb+ flies would have 
closed wings since they represented the genotype P{w+UAS-CG17360+}/CyO; 
E(var)3-501/ PBac{RB}CG17360e02295w-  or  
P[w+;Act5C-Gal4]25FOI/CyO; E(var)3-501/ PBac{RB}CG17360e02295w- . However 
these flies had open wings. This indicated an error in making a stock required for 
this experiment and was not pursued further.  
 
Table 2.25 Rescue of wing phenotype by the UAS-CG17360 transgene 
 
w;P{w+; Act5C-Gal4}25FOI/CyO; 
PBac{RB}CG17360e02295w-/TM6C, Sb Tb 
females         
 
Males 
 Cy+ Sb+ Cy Sb Cy+ Sb Cy Sb+ 
P{w+ UAS-CG17360}/CyO;  
E(var)3-501/TM6C, Sb Tb   #41B 
37 90 62 45 
P{w+ UAS-CG17360}/CyO;  
E(var)3-501/TM6C, Sb Tb   #66B 
4 91 - 40 
P{w+ UAS-CG17360}/CyO;  
E(var)3-501/TM6C, Sb Tb   #28A 




 A dominant enhancer mutation identified as E(var)3-5 was discovered 
along with other E(var) mutations by Dorn et al. (1993) in a mutagenesis screen 
for isolating potential enhancer genes. I pursued experiments to identify the 
E(var)3-5 gene. Initial complementation test performed using Exelixis 
deficiencies indicated that E(var)3-5 maps in the region defined by 
Df(3R)Exel7310. Further complementation analysis using FLP-FRT mediated 
deletions of the region defined by Df(3R)Exel7310 indicated that E(var)3-5 is not 
allelic to the genes of the region defined by Df(3R)Exel7310.  PCR analysis of 
E(var)3-5 alleles indicated the presence of mutations in CG17360 gene. PEV 
assays were done to detect the enhancer effect in 86F6-87A1 region and in 
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CG17360 mutants. The results obtained using different assay are discussed 
below.         
 Complementation tests of E(var)3-5 mutant alleles with Df(3R)D1M1 and 
Df(3R)D2M2 and CG17360 mutants performed in vials versus bottles indicated 
differences. Initial results predicted that E(var)3-5 might be allelic to CG17360 
since a low ratio of the E(var)3-5/PBac{RB}CG17360e02295 was obtained.  
However this ratio was not consistent when the complementation tests were 
repeated in vials and complementation tests done in bottles gave close to the 
expected ratio. These results indicated that the E(var)3-
5/PBac{RB}CG17360e02295 progeny were sensitive to larval density conditions in 
vials and bottles. In a study conducted by Jiro (1962) on larval population density 
versus eclosion rate, it was observed that vials containing a high larval density 
showed a low eclosion percentage of flies. In my complementation test studies 
the inconsistency in the ratio of E(var)3-5/PBac{RB}CG17360e02295 progeny can 
be attributed to larval population density (Jiro 1962). 
 Complementation tests of E(var)3-5 with five FLP-FRT mediated deletions 
indicated that E(var)3-5 is not allelic to any of the genes in the region defined by 
Df(3R)Exel7310. These results indicated that observed lethality of E(var)3-5 
mutants with Df(3R)Exel7310 mutants is due to a cumulative effect of mutations 
in genes in the region defined by Df(3R)Exel7310.   
 The E(var)3-5-/Df(3R)D1M1, E(var)3-5-/Df(3R)D2M2 and E(var)3-5-
/PBac{RB}CG17360e02295 flies exhibited an unexpanded wing phenotype. 
Complementation tests between E(var)3-5 alleles and the PBac{RB}CG17360Rev 
allele revealed that E(var)3-5-/PBac{RB}CG17360Rev progeny had a wild-type 
wing phenotype. These results indicated that E(var)3-5 alleles harbor mutations 
in CG17360 and as a result the E(var)3-5-/PBac{RB}CG17360e02295 flies exhibit 
an unexpanded wing phenotype. PCR analysis of the CG17360 gene in E(var)3-
5 mutant alleles was done to confirm the presence of any associated mutations. 
PCR analysis results revealed that a particular primer set, 3941F-4265R, was 
unable to amplify a 324 base pair region in CG17360 in E(var)3-5- alleles. This 
indicated that CG17360 harbors mutations in between the primer binding sites for 
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primers 3941F and 4265R. The E(var)3-507 also harbored a mutation in this 
region.  
 The E(var)3-4 allele also harbored a mutation in CG17360. One possible 
explanation is that the E(var) alleles might have been confused during stock 
maintenance. Another possibility is that the parental strains used for obtaining 
these mutants originally harbored mutations in CG17360 since E(var)3-5 mutants 
isolated from different mutagenesis screens harbored the same mutation. 
Complementation test between the E(var)3-501 allele and the E(var)3-409 allele 
revealed non-complementation between them. The E(var)3-501/E(var)3-409  flies 
represented 1% of the progeny as opposed to 25%. The CG17360 mutation in 
both the E(var) chromosomes might lead to underepresentation of the progeny, 
resulting in a low ratio. However, the presence of other mutations on the E(var) 
chromosomes is also likely given the low recovery.  
 The nature of the mutation in the E(var)3-5 mutant alleles could not be 
established using PCR alone. I performed a Southern blot analysis on six 
E(var)3-5 alleles to assess the nature of mutation associated with CG17360. The 
six alleles obtained from the Icarus-neo mutagenesis were used. A probe that 
detected 1.0 kb and 1.9 kb DNA fragments in the control Canton S DNA was 
used. It was hypothesized that if the mutation were an insertion, a PstI restriction 
fragment would be disrupted in the E(var)3-5 alleles, and as a result the probe 
would not detect the desired 1.0 and 1.9 kb fragments. The results revealed that 
the 1.0 and 1.9 kb fragments could be detected in all the alleles including the 
control. It can be suggested that the mutation is an inversion of the sequences 
between the Pst1 sites, thereby detecting the expected DNA bands in mutant 
alleles. An unexpected third DNA band of 4 kb was also detected in all the alleles 
including the control Canton S DNA. The band might be due to partial digestion 
of genomic DNA obtained from Canton S and E(var)3-5 alleles, or a 
polymorphism present on the TM6B chromosome.  
 I conducted experiments to determine if the enhancer phenotype of  
E(var)3-5 mutants maps in the region defined by Df(3R)Exel7310.  A wm4 
variegation assay was done to detect the presence of the enhancer phenotype. 
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Inconclusive results were obtained in two separate trials. The wm4 assay should 
be repeated again and should be performed more meticulously. The effect of 
deficiencies was tested on variegation of Stubble (Sb) gene. Df(3R)D4M1 
significantly enhanced Sb variegation in females, indicating the presence of an 
enhancer in the region deleted by this deficiency. However Df(3R)Exel7310 that 
encompasses genes deleted by Df(3R)D4M1 did not enhance Sb variegation. 
These results indicated the presence of other suppressor genes in this region 
that would negate the effect of a enhancer gene. As a result, Df(3R)Exel7310 
flies would fail to enhance Sb variegation. Df(3R)D4M1 males however did not 
enhance Sb variegation. The disparity observed in the results can be attributed to 
the heterochromatic Y chromosome of males. However the experiment needs to 
be repeated again to verify these results.  
 Since the E(var)3-5  alleles harbor mutations in CG17360, I assessed the 
effect of mutation in CG17360 on Sb variegation. Enhancement of Sb variegation 
was not observed for the PBac{RB}CG17360e02295 mutant allele. However the 
results obtained point towards suppression of Sb variegation by the 
PBac{RB}CG17360e02295 mutant allele.  
 The effect of the Df(3R)Exel7310 deletion and mutations in CG17360 
were tested on variegation of the LacZ gene. The results obtained indicated that 
CG17360 mutants do not enhance LacZ variegation, similar to results obtained 
for Sb variegation. However the results also indicated that Df(3R)Exel7310 
mutants enhance LacZ variegation. This is unexpected because Df(3R)Exel7310 
failed to enhance Sb variegation. The LacZ variegation using Df(3R)Exel7310 













Chapter 3: Lethal phase analysis of E(var)3-5 mutants 
 
Introduction  
 The aim of this study was to characterize the lethal phenotype and study 
the effects of the E(var)3-5 mutation as a means to reveal the function of E(var)3-
5. The proposed role of enhancer proteins is to maintain a euchromatic 
chromatin state (Sinclair et al. 1989). Disruption of a euchromatin chromatin state 
due to mutations in enhancer genes has revealed defects during embryogenesis. 
For example, lack of a functional Bramha (brm) gene product results in late 
embryonic lethality in homozygous brm embryos. Defects in maternally 
contributed brm gene product resulted in early embryonic lethality detectable at 
the gastrulation phase (Brizuela et al. 1994). Embryonic defects due to mutations 
in Trithorax-like (Trl) gene have also been recorded (Bhat et al. 1996). The Trl 
locus encodes the GAGA transcription factor (Farkas et al. 1994). The above 
data implicates the importance of E(var) proteins during development.  
  The dominant enhancer mutation E(var)3-5 was identified by Dorn et al. 
(1993b). Six E(var)3-5 alleles were isolated in an Icarus-neo P element 
mutagenesis screen whereas four E(var)3-5 alleles were isolated in a π 2 P 
element mutagenesis screen. All of the E(var)3-5- alleles have been reported to 
be recessive lethal (Dorn et al. 1993b).  
  Previous complementation tests analysis between the seven E(var)3-5 
alleles did not yield any heteroallelic E(var)3-5 adults (Weiler et al. unpublished 
data). Also, lethal analysis of heterozygous E(var)3-501/E(var)3-504  embryos 
revealed variability in timing of lethality and segmentation was observed in most 
of the embryos. However, those studies did not utilize the embryonic marker GFP 
that would unequivocally permit the clear distinction of homozygous E(var)3-5 
embryos from homozygous balancer embryos.  
  My study utilized the balancer chromosome that expresses the embryonic 
marker EGFP (enhanced green fluorescent protein). EGFP was shown to be 
expressed at stage eight during the embryo development (Halfon et al. 2002). 
Stage eight is the germ band extension stage that occurs approximately three 
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hours 45 min after egg laying. Thus the use of EGFP permits early detection and 
distinction of the different genotypes of embryos.  I planned to analyze the 
lethality in homozygous E(var)3-5 embryos and hemizygous E(var)3-5 embryos. 
The homozygous E(var)3-5 embryos and hemizygous E(var)3-5 embryos could 
be recognized as yellow embryos due to yellow embryo fluorescence due to the 
lack of EGFP marker. On the other hand embryos that contained a single copy of 
GFP would have been distinguished due green embryo fluorescence. I planned 
to analyze developmental defects, if any, in yellow embryos using phase contrast 
microscopy (Wieschaus and Nusslein-Wolhard 1998). If the lethality did not occur 
at an embryonic stage but ensued at later stages such as 3rd instar stage it would 
be advantageous to analyze salivary gland chromosomes. Since the proposed 
function of the E(var) class of genes is to promote euchromatin formation, 
observation of salivary gland chromosomes might be helpful to identify any 
defects in chromosome structure such as banding pattern abnormalities.  
  
Materials and methods 
 
Drosophila stocks and culture conditions:  All the strains and crosses were 
maintained in cornmeal-malt medium described as a standard media recipe by 
Bloomington Drosophila Stock Center (http://flystocks.bio.indiana.edu). The 
crosses were established at 25°C unless otherwise noted. The E(var)3-5 mutant 
alleles were isolated by Dorn et al. (1993) and were gifted to our lab by R. Dorn 
and G. Reuter. The synthesis of Df(3R)D1M1 is described in chapter two and all 
other stocks were obtained from the Bloomington Stock center and are described 










Table 3.1 Genotype of strains used for lethality analysis 
 
Analysis of lethal phase:    
 Each of the E(var)3-5- chromosomes (alleles one through six) was 
balanced with the TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
chromosome that expresses the EGFP during embryonic development. 
Homozygous E(var)3-5- embryos were obtained from E(var)3-5-/TM3, P{w+GAL4-
twi.G} P{w+UAS-2xEGFP} Sb Ser males and females. The E(var)3-5/E(var)3-5 
homozygous embryos exhibited a yellow embryo fluorescence due to lack of 
EGFP: a ratio of 25% was expected. The sibling E(var)3-5/TM3, P{w+GAL4-
twi.G} P{w+UAS-2xEGFP} Sb Ser embryos were identified as green embryos and 
exhibited a green embryo fluorescence due to one copy of EGFP; a ratio of 50% 
was expected. The sibling bright-green embryos representing the genotype TM3, 
P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser/TM3, P{w+GAL4-twi.G} P{w+UAS-
2xEGFP} Sb Ser expressed two copies of EGFP and exhibited a bright green 
fluorescence. A ratio of 25% was expected for these embryos.  
 Each of the E(var)3-5- chromosomes (alleles one through six) and 
Df(3R)Exel7310 chromosome was balanced with the TM3, P{w+GAL4-twi.G} 
P{w+UAS-2xEGFP} Sb Ser chromosome that expresses the EGFP during 
embryonic development. Hemizygous E(var)3-5-/Df(3R)Exel7310 embryos were 
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obtained from E(var)3-5-/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
males and Df(3R)Exel7310/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
virgin females. The E(var)3-5-/Df(3R)Exel7310 embryos exhibited a yellow 
embryo fluorescence due to lack of EGFP: a ratio of 25% was expected. The 
sibling E(var)3-5-/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser and 
Df(3R)Exel7310/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser embryos 
were identified as green embryos and exhibited a green embryo fluorescence 
due to one copy of EGFP; a ratio of 50% was expected. The sibling bright-green 
embryos representing the genotype TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} 
Sb Ser/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser expressed two copies 
of EGFP and exhibited a bright green fluorescence. A ratio of 25% was expected 
for these embryos.  
 The PBac{RB}CG17360e02295 and the  Df(3R)D1M1 chromosome was 
balanced with the TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
chromosome that expresses the EGFP during embryonic development. 
Hemizygous PBac{RB}CG17360e02295/ Df(3R)D1M1 embryos were obtained from 
Df(3R)D1M1/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser virgin females 
and PBac{RB}CG17360e02295/ TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
males. The PBac{RB}CG17360e02295/ Df(3R)D1M1 embryos exhibited a yellow 
embryo fluorescence due to lack of EGFP: a ratio of 25% was expected. The 
sibling Df(3R)D1M1/ TM3, P{w+GAL4-twi.G}, P{w+UAS-2xEGFP}, Sb Ser and 
PBac{RB}CG17360e02295/TM3, P{w+GAL4-twi.G}, P{w+UAS-2xEGFP}, Sb Ser 
embryos were identified as green embryos and exhibited a green embryo 
fluorescence due to one copy of EGFP; a ratio of 50% was expected. The sibling 
bright-green embryos representing the genotype TM3, P{w+GAL4-twi.G} 
P{w+UAS-2xEGFP} Sb Ser/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser 
expressed two copies of EGFP and exhibited a bright green fluorescence. A ratio 
of 25% was expected for these embryos.  
 For each experiment, about 100-150 females were combined with 100-
150 males in bottles supplemented with yeast paste. The cultures were 
incubated a minimum of two days prior to embryo collection. Eggs were collected 
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on apple-grape juice agar plates, which were replaced every hour. Once it was 
established that females were laying a constant rate, the freshly laid embryos 
were collected and lined up neatly on apple-grape juice agar plates. The 
embryos were incubated at 25°C and monitored over a period of two days. The 
plates were examined three times during the first day and once or twice on the 
second day. A Leica MS5 stereomicroscope fitted with an epifluorescent 
illuminator and a GFP (470nm) filter was used. Larvae that hatched from yellow 
embryos were transferred to vials. 15-20 larvae were transferred per vial. The 
vials were placed at 25°C. The larvae were observed each day for viability. The 
dead larvae were picked from the vials and their mouthhooks were isolated to 
determine the stage of lethality. The number of teeth in the larval mouthhooks 




Homozygous E(var)3-5-  mutants  exhibit lethality during the embryonic 1st                                                                                                
and 2nd larval instar stages: The hatching rates of homozygous E(var)3-5 
embryos of six E(var)3-5 alleles were analyzed. In brief, the E(var)3-5 females 
were crossed to E(var)3-5 males, both having the EGFP balancer chromosome, 
to obtain three different progeny classes as indicated in Figure 3.1. The 
homozygous yellow embryos contained two mutant copies of E(var)3-5 and were 
assayed for hatching and viability. The heterozygous green embryos of the 
genotype E(var)3-5/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser were 
heterozygous for a wild-type copy of E(var)3-5 and were used as an internal 
control for comparing the hatching rate of embryos. Three to four trials were 
completed for studying the lethality associated with each E(var)3-5 alleles, with a 
minimum of 150 embryos per trial. The results are indicated in Table 3.2. The 
hatching rate in homozygous E(var)3-5 embryos was determined to be more than 
65%. Statistical analysis using one-way ANOVA (P>0.05) indicated no significant 
differences in the hatching rates of homozygous E(var)3-5 embryos having 
different mutant alleles. The hatching rate of heterozygous embryos that 
contained one wild-type copy of E(var)3-5 was more than 90% (Table 3.2). 
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Although a 25% ratio for homozygous E(var)3-5 embryos was expected, a 
slightly higher ratio was observed. Unfertilized embryos might contribute to the  
higher ratio of homozygous E(var)3-5 embryos. 
 
















Table 3.2 Embryonic lethality of homozygous E(var)3-5- mutants 
a The yellow embryos represent the homozygous E(var)3-5 embryos (alleles one 
through six).  
b The green embryos represent the genotype E(var)3-5-/TM3, P{w+GAL4twi.G} 
P{w+UAS-2xEGFP} Sb Ser.   
c The bright green embryos represent the genotype TM3, P{w+GAL4twi.G} 
P{w+UAS-2xEGFP} Sb Ser/TM3, P{w+GAL4twi.G} P{w+UAS-2xEGFP} Sb Ser 
 
 First instar larvae homozygous for E(var)3-5 mutant alleles 02, 03 and 04 
were analyzed for viability. The homozygous E(var)3-5- larvae exhibited lethality 
during the first or second instar stages. A few third instar homozygous E(var)3-
504 were also obtained. However, there was bacterial contamination in the vials 
containing the larvae, and lethality results for all of the larvae could not be 
obtained.  
 
E(var)3-5-/Df(3R)Exel7310 embryos exhibit lethality at the pupal stage:   As 
described in chapter two, Df(3R)Exel7310 failed to complement E(var)3-5 mutant 
alleles, suggesting that E(var)3-5  is present in the region deleted by this 


















































































embryos was determined. In brief, the Df(3R)Exel7310/TM3, P{w+GAL4-twi.G} 
P{w+UAS-2xEGFP}Sb Ser females were crossed to E(var)3-5-/TM3, P{w+GAL4-
twi.G} P{w+UAS-2xEGFP}Sb Ser males to obtain three different progeny classes 
as indicated in Figure 3.1. In yellow hemizygous Df(3R)Exel7310/E(var)3-5- 
embryos the lethality would be due to a single mutant copy of E(var)3-5- or due to 
mutations in any of the genes in that region. The heterozygous green embryos of 
the genotype E(var)3-5 or Df(3R)Exel7310/TM3, P{w+GAL4-twi.G} P{w+UAS-
2xEGFP}Sb Ser were heterozygous for a wild-type copy of E(var)3-5 and were 
used as an internal control for comparing the hatching rate of embryos. Three to 
four trials were completed to analyze the lethality associated with each 
heterozygous allele, with a minimum of 150 embryos per trial.  
 Four of the E(var)3-5 mutant alleles exhibited a hatching rate about 73% 
in the hemizygous state. E(var)3-504 and E(var)3-506 had a lower rate. However, 
statistical analysis using one-way ANOVA indicated no significant difference in 
the hatching rates of hemizygous embryos (P>0.05). The hatching rate of 
heterozygous E(var)3-5 or Df(3R)Exel7310/TM3, P{w+GAL4-twi.G} P{w+UAS-
2xEGFP}Sb Ser embryos that contained one wild-type copy of E(var)3-5 was 
more than 90% (Table 3.3). The percentage of yellow embryos recovered from 
each cross was slightly higher than expected. Unfertilized yellow embryos might 














Table 3.3 Embryonic lethality of hemizygous E(var)3-5/Df(3R)Exel7310 embryos 
 
a The yellow embryos represent the hemizygous E(var)3-5/Df(3R)Exel7310 
embryos (alleles one through six).  
b The green embryos represent the genotype E(var)3-5 or Df(3R)Exel7310/TM3, 
P{w+GAL4twi.G} P{w+UAS-2xEGFP} Sb Ser. 
 c The bright green embryos represent the genotype TM3, P{w+GAL4twi.G} 
P{w+UAS-2xEGFP} Sb Ser/TM3, P{w+GAL4twi.G} P{w+UAS-2xEGFP} Sb Ser. 
 
The lethality of Df(3R)Exel 7310/E(var)3-5 mutant larvae was analyzed. 
For one trial, the hemizygous larvae were placed in vials and analyzed for 
viability. The larval mouthhooks of any dead larvae were isolated to determine 
the larval instar stage. Lethality in these hemizygous larvae was primarily 
manifested during the pupal stage (Table 3.4). The few adults flies that eclosed 







Yellow embryosa Green embryosb Bright green embryosc 





























































































































































a Larvae were designated as unknown when the larvae could not be recovered 
from  vials.  These larvae are not included in the percentages calculated for 
hatched individuals. 
b The wings of the eclosed flies did not expand.  
 
PBac{RB}CG17360e02295/Df(3R)D1M1 mutants exhibit lethality during the 
pupal stage:   Initial complementation tests of E(var)3-5 mutants with CG17360 
mutants done in vials indicated the possibility that E(var)3-5 might be allelic to 
CG17360. This observation was based on the fact that the observed ratio of 
E(var)3-5-/CG17360- progeny was low when a complementation test was 
performed. I therefore analyzed the lethal phase of CG17360- hemizygous 
embryos, to elucidate the function of the CG17360 gene product during 
embryogenesis. The lethality in PBac{RB}CG17360e02295/Df(3R)D1M1 would be 
due to one mutant copy of CG17360. The heterozygous green embryos were 
used as an internal control for comparing the hatching rates of embryos. The 
data derived from a minimum of three trials. The results for lethality are 
summarized in Table 3.5. About 80% of the yellow larvae hatched suggesting 
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that the CG17360 gene product is not essential for embryogenesis or that 
maternally provided gene product is sufficient. The yellow embryos that hatched 
were analyzed for viability. The lethality analysis of PBac{RB}CG17360e02295/ 
Df(3R)D1M1 larvae revealed that in 46% of larvae, lethality is manifested at the 
pupal stage. About 10% of larvae survived until the adulthood phase. The adult 
flies that eclosed exhibited an unexpanded wing phenotype (Table 3.6) 
 
Table 3.5 Embryonic lethality analysis of PBac{RB}CG17360e02295/Df(3R)D1M1  
embryos 
a The yellow embryos represent the hemizygous 
PBac{RB}CG17360e02295/Df(3R)D1M1 embryos (alleles one through six).  
b The green embryos represent the genotype PBac{RB}CG17360e02295or 
Df(3R)D1M1 /TM3, P{w+GAL4twi.G},P{w+UAS-2xEGFP},Sb Ser.  




Table 3.6 Lethality of PBac{RB}CG17360e02295/Df(3R)D1M1 larvae 
aThe unknown larvae were not accounted for when calculating the percentages. 
The larvae were designated unknown when they could not be recovered from 
vials 
b One larva died while molting, as revealed by double mouthooks 
c All  of the adults exhibited unexpanded wings 
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 Position effect variegation involves changes in gene expression as a 
consequence of chromosomal rearrangements. E(var)3-5 was isolated as a 
dominant enhancer mutation in a genetic screen for PEV modifiers (Dorn et al. 
1993b). The E(var)3-5 alleles were reported to be recessive lethal.  
 The embryonic lethality of homozygous E(var)3-5 embryos was analyzed. 
The results indicated that 60-70% of the homozygous E(var)3-5 embryos 
hatched into larvae. Most died as 1st or 2nd instar larvae. The hatching rate in the 
hemizygous E(var)3-5/Df(3R)Exel7310 embryos was recorded to be about 65-
70%. The lethality of hemizygous E(var)3-5 larvae was analyzed.  Most 
hemizygous E(var)3-5 larvae died as pupae. 
 About 20-30% of the homozygous E(var)3-5 and hemizygous E(var)3-
5/Df(3R)Exel7310 embryos did not hatch. Experiments involving the unhatched 
embryos were not pursued further due to their small number.  However it is 
possible that the unhatched embryos were unfertilized. Another possibility is that 
maternal gene product supported the embryonic development of most embryos 
but that the E(var)3-5 gene product was depleted in the unhatched embryos 
resulting in embryonic lethality.     
  The lethality produced in the hemizygous E(var)3-5/Df(3R)Exel7310 
mutant larvae would be due to one mutant copy of E(var)3-5 protein 
(hypomorph/deficiency). On the other hand lethality produced in the homozygous 
E(var)3-5 larvae would be due to two mutant copies of E(var)3-5 protein 
(hypomorph/hypomorph). Thus studying the lethal phase of hemizygous E(var)3-
5 mutants was advantageous compared to  homozygous mutants. The lethality in 
these hemizygous E(var)3-5/Df(3R)Exel7310 larvae is manifested during the 
pupal stage whereas  the lethality in homozygous E(var)3-5 larvae is manifested 
in the early larval instar stages. These results indicate the presence of other 
random mutations in the homozygous E(var)3-5 mutants.  
Since the lethality in E(var)3-5/Df(3R)Exel7310 larvae is manifested primarily at 




 The embryonic lethality of PBac{RB}CG17360e02295/Df(3R)D1M1 embryos 
was analyzed. 80% hatching rate was observed in these embryos. About 20% of 
the embryos remained unhatched. As mentioned earlier these embryos might be 
unfertilized, or may require the maternally contributed gene product for further 
development. The significant lethality during pupal development and the 
observation that those individuals surviving until adulthood had unexpanded 
wings indicates the requirement of the CG17360 protein during the pupal stage 
and for wing development.  
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Chapter 4: Discussion 
 
 Position effect variegation (PEV) is observed as alterations in a gene’s 
expression pattern due its misplacement into a new chromosomal environment. 
For example, a euchromatic gene exhibits variegated expression when displaced 
near heterochromatin due to a translocation or inversion. Heterochromatic genes 
also exhibit variegated expression due to their placement away from 
heterochromatic sequences. The eukaryotic chromosome is organized into two 
domains, euchromatin and heterochromatin. PEV is thus used as a tool to unfold 
mysteries underlying the process of heterochromatinization and chromosome 
structure (reviewed by Weiler and Wakimoto 1995). Dominant mutations of the 
genetic modifier genes of PEV that enhance or suppress the process of 
heterochromatinization have been isolated (reviewed by Schotta et al. 2003). The 
protein products of E(var) genes are predicted to be important for establishing a 
euchromatic chromatin state, whereas Su(var) gene products are implicated in 
maintaining a heterochromatic chromatin state (Reuter and Wolff 1981; Sinclair 
et al. 1983) 
 E(var)3-5 was identified via ten dominant mutant alleles that enhanced 
PEV of In(1)wm4 by Dorn et al. (1993b). The mutant alleles of E(var)3-5 were 
reported to be recessive lethal. Six recessive lethal E(var)3-5 alleles were 
isolated in an Icarus-neo mutagenesis screen and four alleles were isolated in 
the π2 mutagenesis screen. Seven E(var)3-5 alleles, six of which originated from 
the Icarus-neo mutagenesis and the seventh allele that originated from π2 
mutagenesis were provided generously to our lab by Dr. Gunter Reuter.  
 My project was the identification of the E(var)3-5 gene and 
characterization of E(var)3-5 mutations. My first goal was to characterize the 
lethality of E(var)3-5 mutations. Studies on enhancer genes such as mod(mdg4) 
(Buchner et al. 2000), Trl (Farkas et al. 1994), Asx (Sinclair et al. 1998), and E2F 
(Seum et al. 1996) have shown that the protein products of these genes are 
essential for embryogenesis. The lethality analysis of E(var)3-5 mutations was 
undertaken to understand the functions of the E(var)3-5 gene product. In these 
experiments I analyzed the hatching rate and lethality of homozygous E(var)3-5- 
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embryos (alleles 01 through 06) and hemizygous Df(3R)Exel7310/E(var)3-5- 
embryos. Most homozygous E(var)3-5- embryos had a hatching rate around 70% 
and the lethality of homozygous E(var)3-5 larvae was manifested during the first 
or second larval instar stages. An equivalent hatching rate of ~70% was 
observed for the hemizygous Df(3R)Exel7310/E(var)3-5- embryos. 
 The lethality in Df(3R)Exel7310/E(var)3-5- larvae is manifested at the pupal 
stage.  
 Since the E(var)3-5 alleles are recessive lethal and homozygous E(var)3-5 
adults are not observed it was expected that the embryos might have a very low 
hatching rate. However a hatching rate of ~70% for the hemizygous and 
homozygous embryos indicated that zygotic contribution of E(var)3-5 product is 
not essential during embryogenesis or that maternal contribution was sufficient.  
 Analyzing lethality in hemizygous Df(3R)Exel7310/E(var)3-5 embryos was 
advantageous compared to analyzing the lethality in the homozygous E(var)3-5 
embryos. The lethality in the hemizygous embryos would be due to one mutant 
copy of E(var)3-5 (hypomorph/deficiency) compared to lethality of homozygous 
embryos where the lethality would be due to two mutants copies of E(var)3-5 
(hypomorph/hypomorph). Thus the lethality in Df(3R)Exel7310/E(var)3-5 
embryos should be more pronounced due to a lower amount of E(var)3-5 protein 
as compared to homozygous E(var)3-5 embryos. Also in the hemizygous 
embryos, there would be less associated mutations due to a deficiency 
chromosome than homozygous embryos where the associated mutations would 
be present on both the chromosomes. The lethality in homozygous E(var)3-5 
larvae was manifested during the first or second larval instar stages whereas the 
lethality in hemizygous embryos is manifested during the pupal stage. This 
indicated that earlier lethality in homozygous E(var)3-5 larvae might be due to 
other associated mutations.  
 A large number (70%) of hemizygous Df(3R)Exel7310/E(var)3-5  larvae 
die at the pupal stage. This indicates that E(var)3-5 protein product is essential 
for the pupal stage. Lethality in these larvae is also observed at the first and 
second larval instar stage and about 25% unhatched hemizygous embryos are 
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also observed. It is possible that there is a requirement of maternally contributed 
E(var)3-5 protein during the embryonic stage and 1st or 2nd larval stages. 
However appropriate experiments should be performed to verify that maternally 
contributed product is essential. Secondly, the unhatched hemizygous embryos 
should be analyzed to determine whether they are fertilized.   
My second goal was to identify the genetic locus on the third chromosome 
that corresponded to E(var)3-5. The E(var)3-5 mutation was localized to the third 
chromosome by Dorn et al (1993).  Meiotic mapping data showed that E(var)3-5 
was located at map position 3-50.56+/- 0.28 which corresponds to cytological 
location 86DE (Weiler unpublished). Lethality mapping studies of E(var)3-5 done 
in our lab indicated that deficiencies Df(3R)M-Kx1/TM3,Sb Ser and Df(3R)T-32, 
cu sir e/MRS failed to complement E(var)3-5. This suggested that E(var)3-5 was 
present in the region from 86E2-4 to 87B1-5. I continued the approach of 
deficiency mapping the E(var)3-5 lethality. Complementation test results with 
deficiency Df(3R)Exel7310 revealed non-complementation with E(var)3-5 
mutants. These data suggested that the lethality of E(var)3-5 mutants maps to 
the region defined by Df(3R)Exel7310.  
I generated a series of five FLP-FRT mediated deletions in the region 
defined by Df(3R)Exel7310 and carried out complementation tests with E(var)3-5 
mutant alleles. Initial complementation tests done in vials suggested that 
Df(3R)D1M1 and Df(3R)D2M2 mutant alleles failed to complement E(var)3-5 
mutations. Df(3R)D4M1, Df(3R)D5M1 and Df(3R)D7M1 complemented the 
lethality of E(var)3-5 mutants. Further complementation tests were done with 
l(3)neo38 and CG17360 mutants, the two genes deleted by both Df(3R)D1M1 
and Df(3R)D2M2. The results revealed that CG17360 might be allelic to E(var)3-
5 since expected ratio of E(var)3-5/CG17360- progeny was not observed. 
However the ratio of E(var)3-5/CG17360-  progeny was not consistent when the 
complementation tests were repeated in vials. The ratio varied from 1% to 23%.  
Further complementation tests done in bottles yielded a higher ratio of E(var)3-
5/CG17360- progeny. These results indicated that the E(var)3-5/CG17360- 
progeny were sensitive to density condition in bottles versus vials. In vials, if the 
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conditions were even a little crowded, the E(var)3-5/CG17360- progeny  were 
underrepresented. One reason might be that E(var)3-5/CG17360- larvae were not 
healthy and faced competition from sibling progeny. In addition, the adult 
E(var)3-5/CG17360- flies have unexpanded wings and after eclosion, can be 
trapped in the food. Consequently, I may have missed counting many adults that 
were lost in the food. Complementation tests of E(var)3-5 mutants with the 
Df(3R)D1M1, Df(3R)D2M2 and Df(3R)D4M1 mutants done in bottles revealed 
that the deletions partially or fully complemented the lethality of E(var)3-5 
mutations. The complementation test results were intriguing since 
Df(3R)Exel7310 encompasses all of these smaller deletions, and clearly failed to 
complement E(var)3-5 when the crosses were carried out in either bottles or 
vials. Very few E(var)3-5/Df(3R)Exel7310 adult were obtained. These results 
suggest that lethality of E(var)3-5 might be a cumulative effect of mutations in 
genes defined by the Df(3R)Exel7310 region.  
As indicated in chapter three (Table 3.4), the lethality in E(var)3-
5/Df(3R)Exel7310 was manifested primarily at the pupal stage and few adults 
were obtained. These results agree with the complementation test results where 
few E(var)3-5/Df(3R)Exel7310 adults were obtained.  
One interesting observation was that Df(3R)D1M1/E(var)3-501, 
Df(3R)D2M2/E(var)3-501 and E(var)3-501/CG17360- flies had an unexpanded 
wing phenotype. The PBac{RB}CG17360M56  homozygous mutants and the 
PBac{RB}CG17360M56 /PBac{RB}CG17360e02295  flies also exhibited unexpanded 
wings. A revertant allele of CG17360 was generated and complementation tests 
with E(var)3-5 mutant alleles were done. The results revealed that E(var)3-
5/PBac{RB}CG17360Rev  progeny had normal wings. This suggested that loss of 
CG17360 function resulted in an unexpanded wing phenotype and that E(var)3-5 
mutant strains had mutations in CG17360. E(var)3-507/Df(3R)D1M1 flies also had 
an unexpanded wing phenotype. Since the E(var)3-501 and E(var)3-507  alleles 
were isolated in different mutagenesis screens, it is possible that parental strain 
used for obtaining the E(var)3-5 mutations originally harbored mutations in 
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CG17360. The parental strains could not be obtained from Dr. Gunter Reuter to 
verify these observations.  
 The E(var)3-5 mutant alleles were investigated by PCR analysis to 
determine whether mutations exist in the CG17360 gene. The E(var)3-5 alleles 
(one through six)  and E(var)3-507 allele were tested. Initial results revealed that a 
1064bp and 844bp  region defined by primer sets 3219F and 4265R, 3734F and 
4578R could not be amplified indicating the presence of mutation. Further PCR 
analysis, using primer sets that amplified smaller regions, indicated that a 340bp 
sequence defined by primers 3941F and 4265R could not be amplified, indicating 
the presence of a mutation. PCR analysis was done on a E(var)3-409 mutant 
allele using primer sets 3734F-4578R. A 844bp region defined by these primer 
sets could not be amplified thereby indicating the presence of a mutation. The 
E(var)3-5 alleles (01-06) and E(var)3-409 allele were isolated in the Icarus-neo 
mutagenesis. The E(var)3-507 was obtained in a different mutagenesis screen. 
These results further suggest the fact that parental strains used for isolating 
these enhancer mutations originally harbored mutations in CG71360 gene. 
However it is also possible that the E(var) strains could have been confused 
during stock maintenance.  
 Complementation tests between E(var)3-409 and E(var)3-501 mutants in 
vials yielded E(var)3-409/ E(var)3-501 progeny. A low ratio was obtained, which 
was unexpected since E(var)3-5 and the E(var)3-4 mutants should complement 
each other. A probable explanation for this result is that the E(var)3-409/ E(var)3-
501 progeny are underrepresented because both chromosomes harbor a mutation 
in CG17360. The complementation tests should be repeated in bottles to verify 
the results. Another possibility is that during the process of stock maintenance 
the E(var)3-4 stock was confused with the E(var)3-5 stock.   
Southern analysis in six Icarus-neo mutagenized E(var)3-5 alleles was 
done to determine the nature of mutation. PstI digested Canton S DNA and 
E(var)3-5 DNA was probed with a 1064 bp DNA fragment. The probe recognized 
1.0 kb and 1.9 kb  fragments in the control Canton S DNA. It was expected that if 
the mutation is a insertion the PstI restriction fragment in the E(var)3-5 alleles 
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would be disrupted and as a result the probe would recognize fragments other 
than 1.0 and 1.9 kb. But surprisingly, 1.0 kb and 1.9 kb fragments were detected 
in all of the E(var)3-5 alleles. A probable explanation for these observations is 
that all the E(var)3-5 alleles contain an inversion. This inversion is between PstI 
sites, to give the 1.0 and 1.9 kb DNA bands. 
 I tested the effect of E(var)3-501, Df(3R)Exel7310 and four FLP-FRT 
mediated  deletions on PEV of In(1)wm4 and T(2:3)Sbv. The wm4 variegation 
experiment was performed twice. The E(var)3-501 allele enhanced wm4 
variegation in both the trials but data obtained from Df(3R)D1M1 and 
Df(3R)D2M2  was not consistent each time the experiment was repeated. This 
experiment needs to be done more meticulously to get conclusive data.  
The E(var)3-501 and E(var)3-503 alleles enhanced Sb variegation. The 
results also determined that Df(3R)D4M1 females significantly enhanced Sb 
variegation. One interpretation of this result is that that E(var)3-5 phenotype 
maps in the region deleted by this deficiency. In Df(3R)D4M1 males, a significant 
enhancement in Sb variegation was not observed compared to other 
deficiencies. In Df(3R)D4M1 males, the heterochromatic Y chromosome leads to 
a  suppression of Sbv gene as a consequence of which more Stubble bristles are 
observed. However the experiment needs to be repeated again to verify the 
results. 
 I also tested the effect of mutations in CG17360 on Sb variegation. The 
PBac{RB}CG17360e02295 and the Df(3R)CG17360M56 alleles were used. The 
results indicated that CG17360 mutants did not enhance Sb variegation. Instead, 
a suppressive effect was observed. The effect of mutations in the CG17360 gene 
on LacZ variegation were also indicative of a suppressive effect. I also tested the 
effect of Df(3R)Exel7310 on variegation of LacZ gene. Df(3R)Exel7310 enhanced 
LacZ variegation. This result was intriguing since Df(3R)Exel7310 did not 
enhance Sb variegation. The LacZ variegation assay needs to be repeated again 
to verify if the results are repeatable.  
  Is the mutation in CG17360 responsible for the E(var) phenotype of 
E(var)3-5? Based on the Sb variegation results obtained for CG17360 mutants 
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alone, it is possible that mutations in CG17360 are not responsible for the E(var) 
phenotype. However, future experiments involving CG17360 transgene should 
be done to determine whether the transgene rescues the E(var) phenotype. If the 
CG17360 transgene fails to rescue the E(var) phenotype of E(var)3-5, this 
suggests that the E(var) phenotype maps to a different region. If the mapping of 
E(var)3-5 gene is continued, the mapping should be done based on enhancer 
phenotype rather than the lethality phenotype. 
 Does CG17360 mediate heterochromatin formation or is CG17360 a 
suppressor of PEV based on Sb variegation results? Based on the yeast-two 
hybrid interactions by Giot et al. (2003), CG17360 interacts with Pp1-87B, which 
has been identified as a suppressor of PEV (Giot et al. 2003). CG17360 might 
interact with this suppressor and as a result suppress Sb variegation. In addition, 
studies conducted by undergraduate student Catherine Koontz on meiotic 
chromosome segregation on CG17360 mutants revealed that CG17360 mutants 
severely disrupt X-achiasmate disjunction in  
D. melanogaster females. Her results indicated that the CG17360 gene product 
might be essential for heterochromatin formation. The effect of recessive 
mutations in CG17360 should also be tested using PEV assays to detect 
enhancer phenotype if any. 
 In the genetic screen conducted by Dorn et al. (1993b) to isolate enhancer 
mutations, several other E(var) mutations were isolated in the π2 mutagenesis 
screen and Icarus-neo mutagenesis. It would certainly be interesting to analyze 
these E(var) mutants for mutations in CG17360.  
 Over the years molecular characterization of E(var) and Su(var) genes 
has enhanced our knowledge about process of  heterochromatin formation and 
heterochromatin mediated gene silencing. Therefore further experimentation on 






 Previously done mapping studies by graduate student Zhen Li, using P-
element mediated male recombination, indicated that CG3281 might be E(var)3-
5. Mapping data using the P element P{ry+}R307 ry{42} thought to be inserted 
near Hsp70Aa, indicated that E(var)3-5 was distal to it. Mapping data using the 
P{Epgy2}aurEY03490 insertion indicated that E(var)3-5 was proximal to aur. A total 
of fourteen recombinants for P{ry+}R307 ry{42}  and nine recombinants for 
P{Epgy2}aurEY03490 were obtained. Three genes are localized between these two 
P elements: Hsp70Aa, CG3281, and aurora. The Hsp70Aa gene encodes for a 
heat shock protein, and no phenotype was expected for deletion of this gene 
since it is a repeated gene. This indicated that E(var)3-5 mutants were not allelic 
to Hsp70Aa. Complementation tests of E(var)3-5 mutants with aurora 87Ac-3 
mutant allele indicated that E(var)3-5 was not allelic to aurora gene (Weiler 
unpublished). This led to the hypothesis that CG3281 was E(var)3-5. I 
sequenced CG3281 in the E(var)3-5 alleles. I also carried out a P-element 
mediated male recombination experiment to extend Zhen Li’s results. 
 
Materials and methods 
 
Strains and culture conditions:  All of the strains and crosses were maintained 
in cornmeal-malt medium established as a standard media recipe by 
Bloomington Drosophila Stock Center (http://flystocks.bio.indiana.edu). The 
crosses were maintained at 25°C unless otherwise noted. The E(var)3-5 mutants 
alleles were isolated by Dorn et al. (1993) and were  gifted to our lab by R. Dorn 
and G. Reuter. Information of other mutants used in this study is available at 
Flybase (http://flystocks.bio.indiana.edu)   
 
Sequencing CG3281 in E(var)3-5 alleles:  A series of overlapping primers was 
produced for the coding region of CG3281. The primers were designed using the 
software Primer 3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and 
were obtained from Invitrogen company. The primer sets were CG3281 69F (5’- 
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ATCGGGCATCTCTGAACATC-3’) and CG3281 629R (5’- 
GGTCTCCATACTTCTCCTCCATTT-3’), CG3281 523F (5’- 
GGATGTCGTGGAGCTTATAGACCAA-3’) and CG3281 1022R (5’- 
TTGCGTCGGGATGGAATG-3’), CG3281 868F (5’- 
TTCCCAAGCCCACAAACTG-3’) and CG3281 1453R (5’- 
ACCGCACACAAAGCTCTCG-3’), CG3281 1360F (5’- 
TGTGCAGTCCAACGACCTTA-3’) and CG3281 1884R (5’-
TCTAATATACATGGGTTCATTCTACATTCT-3’).  DNA was obtained from ten 
homozygous first instar larvae from all six E(var)3-5 alleles using the protocol of 
Gloor et al. (1993). The PCR products were purified using Exo-SAP-IT (USB) 
and sequenced from both ends at the ISU MRCF. 
 
P-element mediated male recombination:   A P-element mediated male 
recombination experiment was carried out to determine if the E(var)3-5 gene is 
proximal or distal to the P insertion P{wHy}Hsp70AaDG16104  insertion. In the first 
set of crosses st Sbsbd-1 e ro ca virgin females were crossed to yw ; +/Cy0, H{w+ 
PΔ 2-3} ; st E(var)3-504 ca/ P{wHy}Hsp70AaDG16104 males. From the resulting 
cross two phenotypic classes of recombinants were obtained. The phenotypic 
classes were st ca+ and st+ ca recombinants. Out of 1567 males scored, 13 
recombinants were obtained. Complementation tests between w1118; E(var)3-
501/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser females and st ca+ males 
were done . From the resulting cross if Sb+ Tb+ Hu+ progeny were obtained, it 
was determined that E(var)3-5 was distal to the P insertion. Similarly, 
complementation tests between E(var)3-5/TM3, P{w+GAL4-twi.G} P{w+UAS-
2xEGFP} Sb Ser females and st+ ca males were done.  From the resulting cross 
if Sb+ Tb+ Hu+ progeny were obtained, it was determined that E(var)3-5 was 




Sequence analysis of the CG3281 gene:  Since previous results indicated that 
CG3281 was E(var)3-5, I sequenced this gene in E(var)3-5 alleles to determine 
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whether CG3281 contains any mutations. The sequencing results revealed only 
a single nucleotide change in coding sequence which was consistent with all of 
the E(var)3-5 alleles. These results suggested that CG3281 is not E(var)3-5. 
 
P-element mediated male recombination:   The purpose of this experiment 
was to determine whether E(var)3-5 is proximal or distal to the 
P{wHy}Hsp70AaDG16104  insertion at 87A2. P element-mediated male 
recombination was performed by expressing P transposase in st E(var)3-504 ca/ 
P{wHy}Hsp70AaDG16104 males, and selecting progeny that exhibited recombinant 
phenotypes.  Each recombinant chromosome was stocked.  In this experiment 
E(var)3-501/TM3, P{w+GAL4-twi.G} P{w+UAS-2xEGFP} Sb Ser  females were 
crossed to the st ca+ and st+ ca recombinants, for complementation analysis. The 
results are shown in Tables A1, A2, A3 and A4. The results indicated that with st 
ca+ recombinants, E(var)3-501 / st ca+ progeny were not obtained and with st+ ca 
recombinants E(var)3-501 / st+ ca progeny were obtained.  This indicated that the 
st ca+ chromosomes had the E(var)3-504 mutation.   It was thus established that 
E(var)3-5 gene maps proximal to the P{Hy}Hsp70AaDG16104  insertion.  
 
Table A1 Complementation test of E(var)3-5 females with st ca+ recombinant 
males 
 




males Sb Sb+ a 
D2 50 0 
A1* 34 0 
D4 57 0 
Recombinant chromosomes were balanced over the TM3, Sb st e balancer.  






Table A2 Complementation test of E(var)3-5 females with st ca+ recombinant 
males 
Recombinant chromosomes were balanced over the TM6B, Tb Hu e balancer.  
a The absence of Sb+ Tb+ Hu+ e+  progeny is expected if E(var)3-5 is proximal to 
the P insertion  
 
Table A3 Complementation test of E(var)3-5 females with st+ca  recombinant 
males 
 




males Sb Sb+ a 
E1 20 10 
F1 13 29 
D8 20 10 
Recombinant chromosomes were balanced over the TM3, Sb st e balancer.  













males Sb+ Tb Hu e+ Sb e+ Sb e Sb+ Tb+ Hu+ e+ a 
D5 6 5 1 0 
F1* 9 0 14 0 
D2 10 11 7 0 
A1* 26 15 9 0 
D1* 25 17 12 0 
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Table A4 Complementation test of E(var)3-5 females with st+ca  recombinant 
males 
Recombinant chromosomes were balanced over the TM6B, Tb Hu e balancer.  
a The presence of Sb+ Tb+ Hu+ e+ progeny is expected if E(var)3-5 is proximal to 
the P insertion. 
 
 Conclusion 
The sequencing results revealed a single nucleotide polymorphism in 
CG3281 establishing that CG3281 is not allelic to E(var)3-5. Furthermore, the P-
element mediated male recombination data established that the lethality of 
E(var)3-5 is maps proximal to the insertion at 87A. CG3281 is distal to the 
P{wHy}Hsp70AaDG16104  insertion. This further confirms that CG3281 is not 
E(var)3-5. 
E(var)3-501/ TM3,P{w+GAL4-twi.G},P{w+UAS-2xEGFP},Sb Ser 




             Sb
+ Tb Hu e+ Sb e Sb e Sb+ Tb+ Hu+ e+ a 
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